Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Diabetes

Free Subscription Articles published in J Clin Endocrinol Metab Retrieve available abstracts of 600 articles: HTML format

Single Articles

May 2024
1. PRIBITZER S, O'Rourke C, Ylescupidez A, Smithmyer M, et al
   Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 Diabetes.
   J Clin Endocrinol Metab. 2024 May 7:dgae292. doi: 10.1210.
   PubMed     Abstract available
   
   
   
2. DENG R, Chen W, Zhang Z, Zhang J, et al
   Association between visceral obesity index and diabetes: a systematic review and meta-analysis.
   J Clin Endocrinol Metab. 2024 May 6:dgae303. doi: 10.1210.
   PubMed     Abstract available
   
   
   
3. NICOLI CD, Long DL, Plante TB, Judd SE, et al
   N-Terminal Pro-B-Type Natriuretic Peptide and Risk for Diabetes Mellitus and Metabolic Syndrome.
   J Clin Endocrinol Metab. 2024 May 4:dgae301. doi: 10.1210.
   PubMed     Abstract available
   
   
   
4. OKOSHI C, Kyozuka H, Fukuda T, Yasuda S, et al
   Risk of gestational diabetes in women with PCOS based on body mass index: The Japan Environment and Children's Study.
   J Clin Endocrinol Metab. 2024 May 4:dgae293. doi: 10.1210.
   PubMed     Abstract available
   
   
   
5. SCAIRATI R, Auriemma RS, Di Meglio S, Del Vecchio G, et al
   Risk Assessment of Diabetes Mellitus during and after Pregnancy in Women with Prolactinomas.
   J Clin Endocrinol Metab. 2024 May 2:dgae289. doi: 10.1210.
   PubMed     Abstract available
   
   
   April 2024
6. LING P, Yang D, Wang C, Zheng X, et al
   Basal Hyperglycemia Contributes More Than Fifty Percent to Time in Range in Pregnant Women with Type 1 Diabetes.
   J Clin Endocrinol Metab. 2024 Apr 30:dgae291. doi: 10.1210.
   PubMed     Abstract available
   
   
   
7. KAARNIRANTA K, Valtanen M, Keinanen-Kiukaanniemi S, Tuomilehto J, et al
   Long-term cumulative incidence of clinically diagnosed retinopathy in the Finnish Diabetes Prevention Study.
   J Clin Endocrinol Metab. 2024 Apr 25:dgae287. doi: 10.1210.
   PubMed     Abstract available
   
   
   
8. HSU HY, Chern YJ, Hsu MS, Yeh TL, et al
   Colorectal Cancer and Subsequent Diabetes Risk: A Population-based Cohort Study in Taiwan.
   J Clin Endocrinol Metab. 2024 Apr 25:dgae257. doi: 10.1210.
   PubMed     Abstract available
   
   
   
9. HAGELQVIST PG, Andersen A, Maytham K, Andreasen CR, et al
   Hemostatic Effects of Exercise-Related Hypoglycemia in Male Persons With Type 1 Diabetes.
   J Clin Endocrinol Metab. 2024 Apr 20:dgae278. doi: 10.1210.
   PubMed     Abstract available
   
   
   
10. NERILD HH, Gilliam-Vigh H, Ellegaard AM, Forman JL, et al
    Expression of bile acid receptors and transporters along the intestine of patients with type 2 diabetes and controls.
    J Clin Endocrinol Metab. 2024 Apr 18:dgae261. doi: 10.1210.
    PubMed     Abstract available
    
    
    
11. 
    Correction to: "Differential Diagnosis of Post Pancreatitis Diabetes Mellitus Based on Pancreatic and Gut Hormone Characteristics".
    J Clin Endocrinol Metab. 2024 Apr 17:dgae232. doi: 10.1210.
    PubMed    
    
    
    
12. GURUNG RL, Zheng H, Koh HWL, Yiamunaa M, et al
    Plasma proteomics of diabetic kidney disease among Asians with younger-onset type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Apr 16:dgae266. doi: 10.1210.
    PubMed     Abstract available
    
    
    
13. CHE J, He N, Kuang X, Zheng C, et al
    Dietary n-3 fatty acids intake and all-cause and cardiovascular mortality in patients with pre-diabetes and diabetes.
    J Clin Endocrinol Metab. 2024 Apr 16:dgae265. doi: 10.1210.
    PubMed     Abstract available
    
    
    
14. LIANG Q, Li M, Huang G, Li R, et al
    Genetic Susceptibility, Mendelian randomization and Nomogram Model Construction of Gestational Diabetes Mellitus.
    J Clin Endocrinol Metab. 2024 Apr 16:dgae200. doi: 10.1210.
    PubMed     Abstract available
    
    
    
15. DU X, Zhu Y, Lu W, Fu N, et al
    Regulation of the Function of T Follicular Helper Cells and B Cells in Type 1 Diabetes Mellitus by the OX40/OX40L Axis.
    J Clin Endocrinol Metab. 2024 Apr 16:dgae248. doi: 10.1210.
    PubMed     Abstract available
    
    
    
16. ZU P, Wang H, Zhang L, Bian H, et al
    Insulinemic and inflammatory dietary patterns show enhanced predictive potential for gestational diabetes mellitus risk.
    J Clin Endocrinol Metab. 2024 Apr 13:dgae238. doi: 10.1210.
    PubMed     Abstract available
    
    
    
17. LIN X, Zhu K, Qiu Z, Li R, et al
    Associations Between Beverage Consumption and Risk of Microvascular Complications Among Individuals With Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Apr 12:dgae242. doi: 10.1210.
    PubMed     Abstract available
    
    
    
18. LI L, Ji W, Wang Z, Cheng Y, et al
    Air pollution and diabetes mellitus: Association and validation in a desert area in China.
    J Clin Endocrinol Metab. 2024 Apr 9:dgae219. doi: 10.1210.
    PubMed     Abstract available
    
    
    
19. PIEMONTE E, Bruzzaniti S, Galgani M
    Type 2 Diabetes: Fighting Inflammation Fire of T lymphocytes with Magnesium.
    J Clin Endocrinol Metab. 2024 Apr 9:dgae231. doi: 10.1210.
    PubMed    
    
    
    
20. MOON S, Lee M, Lee JS, Lee J, et al
    Association between hypotension during pancreatectomy and development of postoperative diabetes.
    J Clin Endocrinol Metab. 2024 Apr 9:dgae227. doi: 10.1210.
    PubMed     Abstract available
    
    
    
21. FU Y, Lu M, Zhang K, Sun Y, et al
    Vitamin D status, vitamin D receptor polymorphisms, and risk of type 2 diabetes: A prospective cohort study.
    J Clin Endocrinol Metab. 2024 Apr 4:dgae221. doi: 10.1210.
    PubMed     Abstract available
    
    
    
22. WEN H, Niu X, Yu R, Zhao R, et al
    Association of Serum AGR With All-Cause and Cause-Specific Mortality Among Individuals With Diabetes.
    J Clin Endocrinol Metab. 2024 Apr 4:dgae215. doi: 10.1210.
    PubMed     Abstract available
    
    
    
23. PUDDU PE, Menotti A
    Diabetes duration and the reverse impact between cholesterol levels and risk among individuals with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Apr 3:dgae217. doi: 10.1210.
    PubMed    
    
    
    March 2024
24. SAEI GHARE NAZ M, Farhadi-Azar M, Noroozzadeh M, Farahmand M, et al
    Follicle-Stimulating Hormone and Diabetes in Postmenopausal Women: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2024 Mar 30:dgae198. doi: 10.1210.
    PubMed     Abstract available
    
    
    
25. LIU JJ, Liu S, Zheng H, Lee J, et al
    Urine tricarboxylic acid cycle metabolites and risk of end stage kidney disease in patients with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Mar 28:dgae199. doi: 10.1210.
    PubMed     Abstract available
    
    
    
26. QIU Z, Lee DH, Lu Q, Li R, et al
    Associations of Regional Body Fat with Risk of Cardiovascular Disease and Mortality among Individuals with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Mar 26:dgae192. doi: 10.1210.
    PubMed     Abstract available
    
    
    
27. 
    Correction to: "Approach to the Patient With Type 2 Diabetes Requiring Add-On Medication".
    J Clin Endocrinol Metab. 2024 Mar 20:dgae160. doi: 10.1210.
    PubMed    
    
    
    
28. CIARDULLO S, Morabito G, Rea F, Savare L, et al
    Time trends in liver-related mortality in people with and without diabetes: Results from a population based study.
    J Clin Endocrinol Metab. 2024 Mar 20:dgae182. doi: 10.1210.
    PubMed     Abstract available
    
    
    
29. KITAMURA T
    Useful biomarkers and clinical characteristics of post-pancreatitis diabetes mellitus (PPDM).
    J Clin Endocrinol Metab. 2024 Mar 19:dgae174. doi: 10.1210.
    PubMed    
    
    
    
30. DUFT RG, Bonfante ILP, Palma-Duran SA, Chacon-Mikahil MPT, et al
    Moderate-Intensity Combined Training Induces Lipidomic Changes in Individuals with Obesity and Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Mar 15:dgae177. doi: 10.1210.
    PubMed     Abstract available
    
    
    
31. MERTENS J, Roosens L, Braspenning R, Vandebeeck J, et al
    The 13C glucose breath test accurately identifies insulin resistance in people with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Mar 15:dgae175. doi: 10.1210.
    PubMed     Abstract available
    
    
    
32. FRITSCHE L, Loffler D, Kantartzis K, Flehmig G, et al
    Impact of breastfeeding duration on coagulation in women with and without history of gestational diabetes mellitus.
    J Clin Endocrinol Metab. 2024 Mar 15:dgae172. doi: 10.1210.
    PubMed     Abstract available
    
    
    
33. SUPPLI MP, Hogedal A, Bagger JI, Chabanova E, et al
    Signs of Glucagon Resistance After a 2-Week Hypercaloric Diet Intervention.
    J Clin Endocrinol Metab. 2024;109:955-967.
    PubMed     Abstract available
    
    
    
34. THORNTON PS, De Leon DD, Empting S, Zangen D, et al
    Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children.
    J Clin Endocrinol Metab. 2024;109:1071-1079.
    PubMed     Abstract available
    
    
    
35. 
    Correction to: "Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement".
    J Clin Endocrinol Metab. 2024 Mar 14:dgae144. doi: 10.1210.
    PubMed    
    
    
    
36. WONG AYW, Hooi NMF, Yeo BSY, Sultana R, et al
    Improving Diabetic Wound Healing Outcomes with Topical Growth Factor Therapies: Systematic Review and Network Meta-analysis of Randomised-controlled Trials.
    J Clin Endocrinol Metab. 2024 Mar 13:dgae128. doi: 10.1210.
    PubMed     Abstract available
    
    
    
37. SOOY MGQ, Pyle L, Alonso GT, Broncucia HC, et al
    Lower Prevalence of Diabetic Ketoacidosis at Diagnosis in Research Participants Monitored for Hyperglycemia.
    J Clin Endocrinol Metab. 2024 Mar 12:dgae158. doi: 10.1210.
    PubMed     Abstract available
    
    
    
38. CHAN YH, Chao TF, Chen SW, Lee HF, et al
    SGLT2 inhibitors vs. GLP-1 receptor agonists and clinical outcomes in patients with diabetes with/without atrial fibrillation.
    J Clin Endocrinol Metab. 2024 Mar 11:dgae157. doi: 10.1210.
    PubMed     Abstract available
    
    
    
39. LIU W, Cai D, Zhang R, Zhang X, et al
    A randomized clinical trial for meal bolus decision using learning-based control in adults with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Mar 7:dgae143. doi: 10.1210.
    PubMed     Abstract available
    
    
    
40. ALHENC-GELAS F, Marre M
    Young onset type2 diabetes: when gluconeogenesis is overfueled and out of control.
    J Clin Endocrinol Metab. 2024 Mar 5:dgae123. doi: 10.1210.
    PubMed    
    
    
    
41. BOURGONJE AR, Bourgonje MF, Sokooti S, la Bastide-van Gemert S, et al
    Plasma calprotectin and new-onset type 2 diabetes in the general population: a prospective cohort study.
    J Clin Endocrinol Metab. 2024 Mar 4:dgae130. doi: 10.1210.
    PubMed     Abstract available
    
    
    
42. NIELSEN H, Windolf-Nielsen A, Scheuer SH, Damm P, et al
    Type 2 diabetes risk after gestational diabetes according to country/region of origin. A nationwide register-based study.
    J Clin Endocrinol Metab. 2024 Mar 1:dgae113. doi: 10.1210.
    PubMed     Abstract available
    
    
    February 2024
43. LACLAUSTRA M, Alonso-Ventura V, Schipf S, Lou-Bonafonte JM, et al
    Higher Parametric Thyroid Feedback Quantile-based Index is a predictor of type 2 diabetes in a German population sample.
    J Clin Endocrinol Metab. 2024 Feb 29:dgae110. doi: 10.1210.
    PubMed     Abstract available
    
    
    
44. CHEN GC, Hukportie DN, Liu YJ, Wang HP, et al
    Microvascular Disease, Cardiovascular Health, and Risk of Coronary Heart Disease in Type 2 Diabetes: A UK Biobank Study.
    J Clin Endocrinol Metab. 2024 Feb 27:dgae100. doi: 10.1210.
    PubMed     Abstract available
    
    
    
45. CAI Y, Wei Q, Wang S, Lu X, et al
    All-Cause Mortality Differentials by Diabetes Status and Serum Neurofilament Light Chain Levels in U.S. General Adults.
    J Clin Endocrinol Metab. 2024 Feb 27:dgae102. doi: 10.1210.
    PubMed     Abstract available
    
    
    
46. DRENTHEN LCA, Ajie M, de Baaij JHF, Tack CJ, et al
    Magnesium supplementation modulates T-cell function in people with type 2 diabetes and low serum magnesium levels.
    J Clin Endocrinol Metab. 2024 Feb 27:dgae097. doi: 10.1210.
    PubMed     Abstract available
    
    
    
47. RAPINI N, Delvecchio M, Mucciolo M, Ruta R, et al
    The changing landscape of neonatal diabetes mellitus in Italy between 2003-2022.
    J Clin Endocrinol Metab. 2024 Feb 26:dgae095. doi: 10.1210.
    PubMed     Abstract available
    
    
    
48. TRAMONTANA F, Napoli N, Litwack-Harrison S, Bauer DC, et al
    More rapid bone mineral density loss in older men with diabetes: The Osteoporotic Fractures in Men (MrOS) Study.
    J Clin Endocrinol Metab. 2024 Feb 26:dgae045. doi: 10.1210.
    PubMed     Abstract available
    
    
    
49. FRANKS PW
    Look AHEAD to Precision Prevention in Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Feb 22:dgae061. doi: 10.1210.
    PubMed    
    
    
    
50. KALYANI RR, Allende-Vigo MZ, Antinori-Lent KJ, Close KL, et al
    Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement.
    J Clin Endocrinol Metab. 2024 Feb 21:dgad745. doi: 10.1210.
    PubMed     Abstract available
    
    
    
51. HOSHINO Y, Inoue K, Ikeda S, Goshima Y, et al
    Clinical Factors Affecting Daily Dosage of Desmopressin Orally Disintegrating Tablets in Arginine Vasopressin Deficiency.
    J Clin Endocrinol Metab. 2024;109:e983-e996.
    PubMed     Abstract available
    
    
    
52. SAMNANI S, Cenzer I, Kline GA, Lee SJ, et al
    Time to Benefit of Surgery vs Targeted Medical Therapy for Patients With Primary Aldosteronism: A Meta-analysis.
    J Clin Endocrinol Metab. 2024;109:e1280-e1289.
    PubMed     Abstract available
    
    
    
53. QIU S, Cai X, Zhou X, Xu J, et al
    Muscle Quality in Relation to Prediabetes Phenotypes: A Population-Based Study With Mediation Analysis.
    J Clin Endocrinol Metab. 2024;109:e1151-e1158.
    PubMed     Abstract available
    
    
    
54. KIM KM, Kim KJ, Han K, Rhee Y, et al
    Associations Between Physical Activity and the Risk of Hip Fracture Depending on Glycemic Status: A Nationwide Cohort Study.
    J Clin Endocrinol Metab. 2024;109:e1194-e1203.
    PubMed     Abstract available
    
    
    
55. BESCI O, Foss de Freitas MC, Guidorizzi NR, Guler MC, et al
    Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of 115 Cases and a Systematic Review.
    J Clin Endocrinol Metab. 2024;109:e1204-e1224.
    PubMed     Abstract available
    
    
    
56. U-DIN M, Ahmed BA, Syed SA, Ong FJ, et al
    Characteristics of Abdominal Visceral Adipose Tissue, Metabolic Health and the Gut Microbiome in Adults.
    J Clin Endocrinol Metab. 2024;109:680-690.
    PubMed     Abstract available
    
    
    
57. LINGE J, Cariou B, Neeland IJ, Petersson M, et al
    Skewness in Body fat Distribution Pattern Links to Specific Cardiometabolic Disease Risk Profiles.
    J Clin Endocrinol Metab. 2024;109:783-791.
    PubMed     Abstract available
    
    
    
58. KONG YW, Yuan CY, Kiburg K, Brown K, et al
    Treatment satisfaction with Omnipod DASH in adults with type 1 diabetes: A non-blinded 1:1 randomized controlled trial.
    J Clin Endocrinol Metab. 2024 Feb 19:dgae088. doi: 10.1210.
    PubMed     Abstract available
    
    
    
59. BAUM HBA
    Approach to the Patient with Type 2 Diabetes Requiring Add-On Medication.
    J Clin Endocrinol Metab. 2024 Feb 19:dgae056. doi: 10.1210.
    PubMed     Abstract available
    
    
    
60. KIM MK, Lee KN, Han K, Lee SH, et al
    Diabetes duration, cholesterol levels, and risk of cardiovascular diseases in individuals with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Feb 15:dgae092. doi: 10.1210.
    PubMed     Abstract available
    
    
    
61. LV Y, Lu X, Liu G, Qi L, et al
    Differential diagnosis of post pancreatitis diabetes mellitus based on pancreatic and gut hormone characteristics.
    J Clin Endocrinol Metab. 2024 Feb 12:dgae080. doi: 10.1210.
    PubMed     Abstract available
    
    
    
62. HELLEPUTTE S, Stautemas J, Jansseune L, De Backer T, et al
    Glycaemic management around postprandial exercise in people with type 1 diabetes: Challenge accepted.
    J Clin Endocrinol Metab. 2024 Feb 8:dgae079. doi: 10.1210.
    PubMed     Abstract available
    
    
    
63. NABRDALIK K, Kwiendacz H, Irlik K, Hendel M, et al
    Machine learning identifies metabolic dysfunction associated steatotic liver disease in patients with diabetes mellitus.
    J Clin Endocrinol Metab. 2024 Feb 8:dgae060. doi: 10.1210.
    PubMed     Abstract available
    
    
    January 2024
64. MAKINO H, Tohyama M, Kawamura R, Takata Y, et al
    Fulminant type 1 diabetes caused by DIHS could be affected by the reactivation of HHV-6.
    J Clin Endocrinol Metab. 2024 Jan 31:dgae058. doi: 10.1210.
    PubMed     Abstract available
    
    
    
65. ZHU K, Geng T, Qiu Z, Li R, et al
    Beverage Consumption, Genetic Predisposition, and Risk of Cardiovascular Disease among Adults with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Jan 27:dgae050. doi: 10.1210.
    PubMed     Abstract available
    
    
    
66. YU PS, Wu PH, Hung WW, Lin MY, et al
    Association Between Trimethylamine N-oxide and Adverse Kidney Outcomes and Overall Mortality in Type 2 Diabetes Mellitus.
    J Clin Endocrinol Metab. 2024 Jan 24:dgae009. doi: 10.1210.
    PubMed     Abstract available
    
    
    
67. SHAH HS, McGill JB, Hirsch IB, Wu C, et al
    Poor glycemic control is associated with more rapid kidney function decline after the onset of diabetic kidney disease.
    J Clin Endocrinol Metab. 2024 Jan 23:dgae044. doi: 10.1210.
    PubMed     Abstract available
    
    
    
68. 
    Correction to: "Childhood Obesity, Diabetes, and Cardiovascular Disease Risk".
    J Clin Endocrinol Metab. 2024 Jan 20:dgae030. doi: 10.1210.
    PubMed    
    
    
    
69. MULLINS GR, Hodsdon ME, Li YG, Anglin G, et al
    Tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies.
    J Clin Endocrinol Metab. 2024;109:361-369.
    PubMed     Abstract available
    
    
    
70. PARK SS, Ahn CH, Kim SW, Yoon JW, et al
    Subtype-specific Body Composition and Metabolic Risk in Patients With Primary Aldosteronism.
    J Clin Endocrinol Metab. 2024;109:e788-e798.
    PubMed     Abstract available
    
    
    
71. BANERJEE M, Maisnam I, Mukhopadhyay S
    Letter to Editor From Banerjee et al: "Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure".
    J Clin Endocrinol Metab. 2024;109:e873-e874.
    PubMed    
    
    
    
72. MALIN SK
    Understanding the Benefit of Combining GLP-1 Agonists With Exercise: Time Will Tell.
    J Clin Endocrinol Metab. 2024;109:e860-e861.
    PubMed    
    
    
    
73. SABARATNAM R, Kristensen JM, Pedersen AJT, Kruse R, et al
    Acute Exercise Increases GDF15 and Unfolded Protein Response/Integrated Stress Response in Muscle in Type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Jan 18:dgae032. doi: 10.1210.
    PubMed     Abstract available
    
    
    
74. MITA T
    Do digital health technologies hold promise for preventing progression to type 2 diabetes?
    J Clin Endocrinol Metab. 2024 Jan 16:dgae020. doi: 10.1210.
    PubMed    
    
    
    
75. SKOV-JEPPESEN K, Christiansen CB, Hansen LS, Windelov JA, et al
    Effects of exogenous GIP and GLP-2 on bone turnover in individuals with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Jan 13:dgae022. doi: 10.1210.
    PubMed     Abstract available
    
    
    
76. SCHIMPFLE L, Tsilingiris D, Mooshage CM, Kender Z, et al
    Phase angle of bioelectrical impedance analysis as an indicator for diabetic polyneuropathy in type 2 diabetes mellitus.
    J Clin Endocrinol Metab. 2024 Jan 12:dgad737. doi: 10.1210.
    PubMed     Abstract available
    
    
    
77. LIU Y, Liu X, He Q, Huang X, et al
    Changes in isoleucine, sarcosine, and dimethylglycine during OGTT as risk factors for diabetes.
    J Clin Endocrinol Metab. 2024 Jan 12:dgae018. doi: 10.1210.
    PubMed     Abstract available
    
    
    
78. CLINCK I, Mertens J, Wouters K, Dirinck E, et al
    Insulin resistance and CGM-derived parameters in people with type 1 diabetes: are they associated?
    J Clin Endocrinol Metab. 2024 Jan 10:dgae015. doi: 10.1210.
    PubMed     Abstract available
    
    
    
79. LI X, Liu Y, Qi Y, Wu Y, et al
    Maternal serum polyols and its link to gestational diabetes mellitus: A population-based nested case-control study.
    J Clin Endocrinol Metab. 2024 Jan 8:dgae002. doi: 10.1210.
    PubMed     Abstract available
    
    
    
80. BAKER JF, England BR, Wysham KD, Sauer B, et al
    Associations between Adiponectin and the Development of Diabetes in Rheumatoid Arthritis.
    J Clin Endocrinol Metab. 2024 Jan 8:dgae010. doi: 10.1210.
    PubMed     Abstract available
    
    
    
81. PARK SY, Jun JE, Jeong IK, Ahn KJ, et al
    Comparison of the Efficacy of Ezetimibe Combination Therapy and High-Intensity Statin Monotherapy in Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Jan 4:dgad714. doi: 10.1210.
    PubMed     Abstract available
    
    
    
82. ROMERES D, Yadav Y, Ruchi FNU, Carter R, et al
    Hyperglycemia suppresses Lactate Clearance during Exercise in Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Jan 4:dgae005. doi: 10.1210.
    PubMed     Abstract available
    
    
    
83. LOW S, Moh A, Pandian B, Tan XL, et al
    Association between Plasma LRG1 and Lower Cognitive Function in Asians with Type 2 Diabetes Mellitus.
    J Clin Endocrinol Metab. 2024 Jan 3:dgad768. doi: 10.1210.
    PubMed     Abstract available
    
    
    
84. XIONG Q, Li F, Chi H, Yang Y, et al
    Orthostatic hypotension promotes the progression from mild cognitive impairment to dementia in type 2 diabetes mellitus.
    J Clin Endocrinol Metab. 2024 Jan 2:dgad764. doi: 10.1210.
    PubMed     Abstract available
    
    
    December 2023
85. ZHANG Z, Luo S, Xiao Z, Yin W, et al
    Hsa_circRNA_405498 and hsa_circRNA_100033 serve as potential biomarkers for differential diagnosis of type 1 diabetes.
    J Clin Endocrinol Metab. 2023 Dec 29:dgad761. doi: 10.1210.
    PubMed     Abstract available
    
    
    
86. PEREA V, Vinagre I, Seres-Noriega T, Vinals C, et al
    Impact of preeclampsia and parity on sex-based discrepancies in subclinical carotid atherosclerosis in type 1 diabetes.
    J Clin Endocrinol Metab. 2023 Dec 27:dgad755. doi: 10.1210.
    PubMed     Abstract available
    
    
    
87. HANDELSMAN DJ, Grossmann M, Yeap BB, Stuckey BGA, et al
    Long-term Outcomes of Testosterone Treatment in Men: A T4DM Postrandomization Observational Follow-up Study.
    J Clin Endocrinol Metab. 2023;109:e25-e31.
    PubMed     Abstract available
    
    
    
88. OLIVERAS-CANELLAS N, Moreno-Navarrete JM, Lorenzo PM, Garrido-Sanchez L, et al
    Downregulated Adipose Tissue Expression of Browning Genes With Increased Environmental Temperatures.
    J Clin Endocrinol Metab. 2023;109:e145-e154.
    PubMed     Abstract available
    
    
    
89. ZHAO L, Li W, Liu L, Duan L, et al
    Clinical Features and Outcome Analysis of Type B Insulin Resistance Syndrome: A Single-Center Study in China.
    J Clin Endocrinol Metab. 2023;109:e175-e181.
    PubMed     Abstract available
    
    
    
90. SCHAICH CL, Bancks MP, Hayden KM, Ding J, et al
    Visit-to-Visit Glucose Variability, Cognition, and Global Cognitive Decline: The Multi-Ethnic Study of Atherosclerosis.
    J Clin Endocrinol Metab. 2023;109:e243-e252.
    PubMed     Abstract available
    
    
    
91. LI R, Geng T, Li L, Lu Q, et al
    Associations of Glucose Metabolism Status with Brain Macrostructure and Microstructure: Findings from the UK Biobank.
    J Clin Endocrinol Metab. 2023;109:e234-e242.
    PubMed     Abstract available
    
    
    
92. KIM BY, Lee JI, Lee HM, Kim SH, et al
    Association of Blood Pressure With Cardio-Renal Events and Mortality in Type 2 DM: A National Health Insurance Database.
    J Clin Endocrinol Metab. 2023;109:227-236.
    PubMed     Abstract available
    
    
    
93. FERREIRA JP, Sharma A, Butler J, Packer M, et al
    Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure.
    J Clin Endocrinol Metab. 2023;109:4-9.
    PubMed     Abstract available
    
    
    
94. RETNAKARAN R, Kashyap SR, Gerstein HC, Aroda VR, et al
    Contemporary Clinical Perspectives on Targeting Remission of Type 2 diabetes.
    J Clin Endocrinol Metab. 2023 Dec 18:dgad746. doi: 10.1210.
    PubMed     Abstract available
    
    
    
95. VEZZA T, Victor VM
    SIRT1 and miR-34a-5p: valuable biomarkers for the early detection of cognitive impairment in type 2 diabetes mellitus.
    J Clin Endocrinol Metab. 2023 Dec 16:dgad740. doi: 10.1210.
    PubMed    
    
    
    
96. CELIK KAVAKLILAR B, Aybi Ozdemir O, Yildirim T, Dikmetas O, et al
    Evaluation of Microvascular Complications in Kidney Recipients with Post-Transplant Diabetes Mellitus.
    J Clin Endocrinol Metab. 2023 Dec 15:dgad738. doi: 10.1210.
    PubMed     Abstract available
    
    
    
97. PRINCE RL
    New Data on the Increased hip Fracture Risk in Type 2 Diabetes and Its Reduction in Those With High Physical Activity.
    J Clin Endocrinol Metab. 2023 Dec 14:dgad712. doi: 10.1210.
    PubMed    
    
    
    
98. HUANG T, Zhu Y, Shutta KH, Balasubramanian R, et al
    A Plasma Metabolite Score Related to Psychological Distress and Diabetes Risk: A Nested Case-control Study in US Women.
    J Clin Endocrinol Metab. 2023 Dec 13:dgad731. doi: 10.1210.
    PubMed     Abstract available
    
    
    
99. TSAITLIN-MOR L, Cahen-Peretz A, Bentov Y, Ben-Shushan T, et al
    Long-Term Risk for Type 1 Diabetes and Obesity in Early Term Born Offspring: A Systematic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2023 Dec 11:dgad715. doi: 10.1210.
    PubMed     Abstract available
    
    
    
100. HOOPER AJ
     Letter to the Editor from Hooper: Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study".
     J Clin Endocrinol Metab. 2023 Dec 11:dgad719. doi: 10.1210.
     PubMed    
     
     
     
101. WU HX, Chu TY, Iqbal J, Jiang HL, et al
     Response to Letter to the Editor from Hooper: Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study.
     J Clin Endocrinol Metab. 2023 Dec 9:dgad720. doi: 10.1210.
     PubMed    
     
     
     
102. HERNANDEZ N, Lokhnygina Y, Ramaker ME, Ilkayeva O, et al
     Sex differences in branched-chain amino acid and tryptophan metabolism and pathogenesis of youth-onset type 2 diabetes.
     J Clin Endocrinol Metab. 2023 Dec 8:dgad708. doi: 10.1210.
     PubMed     Abstract available
     
     
     
103. CHEN X, Zhang Y, Lin L, Huang L, et al
     A healthy low-carbohydrate diet during pregnancy is associated with a reduced risk of gestational diabetes mellitus.
     J Clin Endocrinol Metab. 2023 Dec 6:dgad705. doi: 10.1210.
     PubMed     Abstract available
     
     
     
104. ALI AS, Pham C, Morahan G, Ekinci EI, et al
     Genetic risk scores identify people at high risk of developing diabetic kidney disease: A systematic review.
     J Clin Endocrinol Metab. 2023 Dec 1:dgad704. doi: 10.1210.
     PubMed     Abstract available
     
     
     
105. TATSUMI Y, Miyamoto Y, Asayama K, Satoh M, et al
     Characteristics and risk of diabetes in people with rare glucose response curve during an oral glucose tolerance test.
     J Clin Endocrinol Metab. 2023 Dec 1:dgad698. doi: 10.1210.
     PubMed     Abstract available
     
     
     November 2023
106. MCELWAIN CJ, Manna S, Musumeci A, Sylvester I, et al
     Defective Visceral Adipose Tissue Adaptation in Gestational Diabetes Mellitus.
     J Clin Endocrinol Metab. 2023 Nov 30:dgad699. doi: 10.1210.
     PubMed     Abstract available
     
     
     
107. WU L, Carlino MS, Brown DA, Long GV, et al
     Checkpoint inhibitor associated autoimmune diabetes mellitus is characterised by C-peptide loss and pancreatic atrophy.
     J Clin Endocrinol Metab. 2023 Nov 24:dgad685. doi: 10.1210.
     PubMed     Abstract available
     
     
     
108. CIARDULLO S, Dodesini AR, Lepore G, Corsi A, et al
     Development of a new model of insulin sensitivity in patients with type 2 diabetes and association with mortality.
     J Clin Endocrinol Metab. 2023 Nov 22:dgad682. doi: 10.1210.
     PubMed     Abstract available
     
     
     
109. UHL S, Choure A, Rouse B, Loblack A, et al
     Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
     J Clin Endocrinol Metab. 2023 Nov 21:dgad652. doi: 10.1210.
     PubMed     Abstract available
     
     
     
110. BANCKS MP, Pilla SJ, Balasubramanyam A, Yeh HC, et al
     Association of lifestyle intervention with risk for cardiovascular events differs by level of glycated hemoglobin.
     J Clin Endocrinol Metab. 2023 Nov 18:dgad674. doi: 10.1210.
     PubMed     Abstract available
     
     
     
111. DIETSCHE KB, Magge SN, Dixon SA, Davis FS, et al
     Glycemia and Gluconeogenesis with Metformin and Liraglutide: A Randomized Trial in Youth-onset Type 2 Diabetes.
     J Clin Endocrinol Metab. 2023 Nov 15:dgad669. doi: 10.1210.
     PubMed     Abstract available
     
     
     
112. STAMOU MI, Smith KT, Kim H, Balasubramanian R, et al
     Polycystic Ovarian Syndrome Physiologic Pathways Implicated Through Clustering of Genetic Loci.
     J Clin Endocrinol Metab. 2023 Nov 15:dgad664. doi: 10.1210.
     PubMed     Abstract available
     
     
     
113. OKADA A, Yamaguchi S, Imaizumi T, Oba K, et al
     Modification effects of albuminuria on the association between kidney function and development of anemia in diabetes.
     J Clin Endocrinol Metab. 2023 Nov 13:dgad660. doi: 10.1210.
     PubMed     Abstract available
     
     
     
114. LI S, Cui M, Liu Y, Liu X, et al
     Metabolic profiles of type 2 diabetes and their association with renal complications.
     J Clin Endocrinol Metab. 2023 Nov 2:dgad643. doi: 10.1210.
     PubMed     Abstract available
     
     
     
115. LAM S, Lee CH, Fong CHY, Wong Y, et al
     Serum Tsukushi level is associated with the severity of liver fibrosis independent of type 2 diabetes.
     J Clin Endocrinol Metab. 2023 Nov 2:dgad650. doi: 10.1210.
     PubMed     Abstract available
     
     
     
116. ROSENBERG EA, Seely EW
     Long-term Cardiovascular Disease After Adverse Pregnancy Outcomes.
     J Clin Endocrinol Metab. 2023 Nov 2:dgad600. doi: 10.1210.
     PubMed     Abstract available
     
     
     
117. MENON JC, Singh P, Archana A, Singh P, et al
     High frequency of recessive WFS1 mutations among Indian children with islet antibody-negative type 1 diabetes.
     J Clin Endocrinol Metab. 2023 Nov 1:dgad644. doi: 10.1210.
     PubMed     Abstract available
     
     
     
118. KITAZAWA M, Takeda Y, Hatta M, Horikawa C, et al
     "Lifestyle Intervention with Smartphone app and isCGM for People at High Risk of Type 2 Diabetes: Randomized Trial".
     J Clin Endocrinol Metab. 2023 Nov 1:dgad639. doi: 10.1210.
     PubMed     Abstract available
     
     
     
119. DAVIS WA, Hamilton E, Davis TME
     Temporal trends in distal symmetric polyneuropathy in type 2 diabetes: The Fremantle Diabetes Study.
     J Clin Endocrinol Metab. 2023 Nov 1:dgad646. doi: 10.1210.
     PubMed     Abstract available
     
     
     
120. NAKASONE Y, Miyakoshi T, Sakuma T, Toda S, et al
     Hemoglobin Glycation Index, A Novel Risk Factor for Incident Chronic Kidney Disease in Apparently Healthy Population.
     J Clin Endocrinol Metab. 2023 Nov 1:dgad638. doi: 10.1210.
     PubMed     Abstract available
     
     
     
121. ROCHA T, Melson E, Zamora J, Fernandez-Felix BM, et al
     Sex-Specific Obesity and Cardiometabolic Disease Risks in Low- and Middle-Income Countries: A Meta-Analysis Involving 3 916 276 Individuals.
     J Clin Endocrinol Metab. 2023 Nov 1:dgad599. doi: 10.1210.
     PubMed     Abstract available
     
     
     October 2023
122. ZENG C, Liu M, Zhang Y, Deng S, et al
     Association of Urine Albumin-to-Creatinine Ratio with Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus.
     J Clin Endocrinol Metab. 2023 Oct 31:dgad645. doi: 10.1210.
     PubMed     Abstract available
     
     
     
123. IMAMURA S, Niwano F, Babaya N, Hiromine Y, et al
     High incidence of diabetes mellitus after distal pancreatectomy and its predictors: A long-term follow-up study.
     J Clin Endocrinol Metab. 2023 Oct 27:dgad634. doi: 10.1210.
     PubMed     Abstract available
     
     
     
124. COSSON E, Thioye EMM, Tatulashvili S, Vicaut E, et al
     The Prognosis of Glutamic Acid Decarboxylase Antibodies in Women With Hyperglycemia in Pregnancy.
     J Clin Endocrinol Metab. 2023 Oct 27:dgad617. doi: 10.1210.
     PubMed     Abstract available
     
     
     
125. HIRSCHBERG AL
     Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women-What Is the Evidence?
     J Clin Endocrinol Metab. 2023 Oct 27:dgad590. doi: 10.1210.
     PubMed     Abstract available
     
     
     
126. DESOUZA CV, Rosenstock J, Kohzuma T, Fonseca VA, et al
     Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine.
     J Clin Endocrinol Metab. 2023;108:e1193-e1198.
     PubMed     Abstract available
     
     
     
127. CEFALO CMA, Riccio A, Fiorentino TV, Succurro E, et al
     Metabolic Syndrome and C-reactive Protein are Associated With a Reduced Myocardial Mechano-energetic Efficiency.
     J Clin Endocrinol Metab. 2023;108:e1264-e1271.
     PubMed     Abstract available
     
     
     
128. MELCHIORSEN JU, Sorensen KV, Bork-Jensen J, Kizilkaya HS, et al
     Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic Phenotypes.
     J Clin Endocrinol Metab. 2023;108:2821-2833.
     PubMed     Abstract available
     
     
     
129. CLEMENTE M, Cobo P, Antolin M, Campos A, et al
     Genetics and Natural History of Non-pancreatectomized Patients With Congenital Hyperinsulinism Due to Variants in ABCC8.
     J Clin Endocrinol Metab. 2023;108:e1316-e1328.
     PubMed     Abstract available
     
     
     
130. BROOME DT
     SGLT-2 Inhibitors: Discrepancy Between MACE Reduction and Incident MI and Stroke.
     J Clin Endocrinol Metab. 2023;108:e1450-e1451.
     PubMed    
     
     
     
131. HERDER C, Maalmi H, Saatmann N, Zaharia OP, et al
     Correlates of Skeletal Muscle Mass and Differences Between Novel Subtypes in Recent-onset Diabetes.
     J Clin Endocrinol Metab. 2023 Oct 13:dgad605. doi: 10.1210.
     PubMed     Abstract available
     
     
     
132. 
     Correction to "Autoimmune Diabetes From Chilhood to Adulthood: The Role of Pancreatic Autoantibodies and HLA-DRB1 Genotype".
     J Clin Endocrinol Metab. 2023 Oct 13:dgad609. doi: 10.1210.
     PubMed    
     
     
     
133. MANDAL N, Stentz F, Asuzu PC, Nyenwe E, et al
     Plasma sphingolipid profile of healthy black and white adults differs based on their parental history of type 2 diabetes.
     J Clin Endocrinol Metab. 2023 Oct 7:dgad595. doi: 10.1210.
     PubMed     Abstract available
     
     
     
134. OU SH, Chang WC, Wu LY, Wang SI, et al
     Diabetic macular oedema is predictive of renal failure in patients with diabetes mellitus and chronic kidney disease.
     J Clin Endocrinol Metab. 2023 Oct 6:dgad581. doi: 10.1210.
     PubMed     Abstract available
     
     
     
135. CARETTA N, Scafa R, Graziani A, Crepaldi MC, et al
     Non-invasive indices of MASLD are associated with hypogonadism in male patients with type 2 diabetes mellitus.
     J Clin Endocrinol Metab. 2023 Oct 5:dgad586. doi: 10.1210.
     PubMed     Abstract available
     
     
     
136. DUAN X, Chen Z, Xia C, Zhong R, et al
     Increased levels of urine volatile organic compounds are associated with diabetes risk and impaired glucose homeostasis.
     J Clin Endocrinol Metab. 2023 Oct 4:dgad584. doi: 10.1210.
     PubMed     Abstract available
     
     
     September 2023
137. NISSEN PEDERSEN AK, Gormsen LC, Nielsen S, Jessen N, et al
     Metformin Improves the Prerequisites for FGF21 Signaling in Patients with Type 2 Diabetes.
     J Clin Endocrinol Metab. 2023 Sep 30:dgad583. doi: 10.1210.
     PubMed     Abstract available
     
     
     
138. LIU X, Zhao Z, Chen D, Zhang Z, et al
     SIRT1 and miR-34a-5p expression in PBMCs as potential biomarkers for Type 2 Diabetes Patients with Cognitive Impairments.
     J Clin Endocrinol Metab. 2023 Sep 27:dgad562. doi: 10.1210.
     PubMed     Abstract available
     
     
     
139. ZHAO Y, Li Y, Zhuang Z, Song Z, et al
     Frequency of adding salt to foods, genetic susceptibility, and incident type 2 diabetes: a prospective cohort study.
     J Clin Endocrinol Metab. 2023 Sep 27:dgad544. doi: 10.1210.
     PubMed     Abstract available
     
     
     
140. MEYER EJ, Wittert GA
     Approach the patient with obstructive sleep apnea and obesity.
     J Clin Endocrinol Metab. 2023 Sep 27:dgad572. doi: 10.1210.
     PubMed     Abstract available
     
     
     
141. TAO X, Liu L, Ma P, Hu J, et al
     Association of Circulating Very Long Chain Saturated Fatty Acids with Cardiovascular Mortality in NHANES 2015-2016.
     J Clin Endocrinol Metab. 2023 Sep 21:dgad561. doi: 10.1210.
     PubMed     Abstract available
     
     
     
142. FAVERO V, Eller-Vainicher C, Morelli V, Cairoli E, et al
     Increased risk of vertebral fractures in patients with mild autonomous cortisol secretion.
     J Clin Endocrinol Metab. 2023 Sep 21:dgad560. doi: 10.1210.
     PubMed     Abstract available
     
     
     
143. ANAWALT BD
     TRAVERSING the Mountain of Ignorance: Testosterone and Cardiovascular Safety.
     J Clin Endocrinol Metab. 2023 Sep 21:dgad555. doi: 10.1210.
     PubMed    
     
     
     
144. TSILINGIRIS D, Schimpfle L, von Rauchhaupt E, Sulaj A, et al
     Dysmetabolism-related Early Sensory Deficits and Their Relationship With Peripheral Neuropathy Development.
     J Clin Endocrinol Metab. 2023;108:e979-e988.
     PubMed     Abstract available
     
     
     
145. ROSENBERG EA, Seely EW, James K, Soffer MD, et al
     Carbohydrate Intake and Oral Glucose Tolerance Test Results in the Postpartum Period.
     J Clin Endocrinol Metab. 2023;108:e1007-e1012.
     PubMed     Abstract available
     
     
     
146. TJADEN AH, Edelstein SL, Arslanian S, Barengolts E, et al
     Reproducibility of Glycemic Measures Among Dysglycemic Youth and Adults in the RISE Study.
     J Clin Endocrinol Metab. 2023;108:e1125-e1133.
     PubMed     Abstract available
     
     
     
147. LUNDQVIST MH, Pereira MJ, Almby K, Hetty S, et al
     Regulation of the cortisol axis, glucagon and growth hormone by glucose is altered in prediabetes and type 2 diabetes.
     J Clin Endocrinol Metab. 2023 Sep 14:dgad549. doi: 10.1210.
     PubMed     Abstract available
     
     
     
148. HUANG X, Li Y, Tong X, Wu Y, et al
     Increased Circulating IL-32 is Associated with Placenta Macrophage-derived IL-32 and Gestational Diabetes Mellitus.
     J Clin Endocrinol Metab. 2023 Sep 14:dgad531. doi: 10.1210.
     PubMed     Abstract available
     
     
     
149. SOUTH AM, Rigdon J, Voruganti S, Stafford JM, et al
     Uric Acid is Not Associated with Cardiovascular Health in Youth with Type 1 Diabetes: SEARCH for Diabetes in Youth Study.
     J Clin Endocrinol Metab. 2023 Sep 10:dgad534. doi: 10.1210.
     PubMed     Abstract available
     
     
     
150. 
     Correction to "Association of Gestational Diabetes With the Dynamic Changes of Gut Microbiota in Offspring From 1 to 6 Months of Age".
     J Clin Endocrinol Metab. 2023 Sep 8:dgad529. doi: 10.1210.
     PubMed    
     
     
     
151. RAMZY A, Saber N, Bruin JE, Thompson DM, et al
     Thyroid hormone levels correlate with the maturation of implanted pancreatic endoderm cells in patients with type 1 diabetes.
     J Clin Endocrinol Metab. 2023 Sep 6:dgad499. doi: 10.1210.
     PubMed     Abstract available
     
     
     August 2023
152. HUANG K, Su S, Wang X, Hu M, et al
     Association between maternal thyroid function in early pregnancy and gestational diabetes: a prospective cohort study.
     J Clin Endocrinol Metab. 2023 Aug 30:dgad518. doi: 10.1210.
     PubMed     Abstract available
     
     
     
153. CHUNG ST, Davis F, Patel T, Mabundo L, et al
     Reevaluating First-Line Therapies in Youth-onset Type 2 Diabetes.
     J Clin Endocrinol Metab. 2023 Aug 25:dgad508. doi: 10.1210.
     PubMed     Abstract available
     
     
     
154. FRIAS JP, Galindo RJ, Wang H, Malik RE, et al
     Tirzepatide in Hispanic/Latino Patients with Type 2 Diabetes: A Subgroup Analysis of the SURPASS program.
     J Clin Endocrinol Metab. 2023 Aug 21:dgad495. doi: 10.1210.
     PubMed     Abstract available
     
     
     
155. JEE YH, Jumani S, Mericq V
     The Association of Accelerated Early Growth, Timing of Puberty, and Metabolic Consequences in Children.
     J Clin Endocrinol Metab. 2023;108:e663-e670.
     PubMed     Abstract available
     
     
     
156. XIE C, Huang W, Sun Y, Xiang C, et al
     Disparities in the Glycemic and Incretin Responses to Intraduodenal Glucose Infusion Between Healthy Young Men and Women.
     J Clin Endocrinol Metab. 2023;108:e712-e719.
     PubMed     Abstract available
     
     
     
157. GREEN DJ, Chasland LC, Naylor LH, Yeap BB, et al
     New Horizons: Testosterone or Exercise for Cardiometabolic Health in Older Men.
     J Clin Endocrinol Metab. 2023;108:2141-2153.
     PubMed     Abstract available
     
     
     
158. SOTO-PEDRE E, Lin YY, Soto-Hernaez J, Newey PJ, et al
     Morbidity Associated With Primary Hyperparathyroidism-A Population-based Study With a Subanalysis on Vitamin D.
     J Clin Endocrinol Metab. 2023;108:e842-e849.
     PubMed     Abstract available
     
     
     
159. PANE A, Viaplana J, Giro O, Llopis J, et al
     Effects of bariatric surgery on blood and vascular large extracellular vesicles according to type 2 diabetes status.
     J Clin Endocrinol Metab. 2023 Aug 17:dgad473. doi: 10.1210.
     PubMed     Abstract available
     
     
     
160. HITT TA, Hannon TS, Magge SN
     Approach to the Patient with Youth-Onset Type 2 Diabetes.
     J Clin Endocrinol Metab. 2023 Aug 16:dgad482. doi: 10.1210.
     PubMed     Abstract available
     
     
     
161. MOOSHAGE CM, Tsilingiris D, Schimpfle L, Kender Z, et al
     Insulin resistance is associated with the capillary permeability of thigh muscles in patients with type 2 diabetes.
     J Clin Endocrinol Metab. 2023 Aug 15:dgad481. doi: 10.1210.
     PubMed     Abstract available
     
     
     
162. YLESCUPIDEZ A, Speake C, Pietropaolo SL, Wilson DM, et al
     OGTT metrics surpass continuous glucose monitoring data for T1D prediction in multiple-autoantibody-positive individuals.
     J Clin Endocrinol Metab. 2023 Aug 13:dgad472. doi: 10.1210.
     PubMed     Abstract available
     
     
     
163. HUANG PS, Cheng JF, Chen JJ, Wang YC, et al
     Higher Risk of Incident Hyperthyroidism in Patients With Atrial Fibrillation.
     J Clin Endocrinol Metab. 2023 Aug 11:dgad448. doi: 10.1210.
     PubMed     Abstract available
     
     
     
164. PARK J, Ntelis S, Yunasan E, Downton KD, et al
     Glucagon-like peptide 1 Analogues as Adjunctive Therapy for Patients with Type 1 Diabetes: an Updated Systematic Review and Meta-analysis.
     J Clin Endocrinol Metab. 2023 Aug 10:dgad471. doi: 10.1210.
     PubMed     Abstract available
     
     
     
165. BILLINGS LK, Shi Z, Wei J, Rifkin AS, et al
     Utility of polygenic scores for differentiating diabetes diagnosis among patients with atypical phenotypes of diabetes.
     J Clin Endocrinol Metab. 2023 Aug 10:dgad456. doi: 10.1210.
     PubMed     Abstract available
     
     
     
166. FERNANDES SILVA L, Hokkanen J, Vangipurapu J, Oravilahti A, et al
     Metabolites as Risk Factors for Diabetic Retinopathy in Patients with Type 2 Diabetes: a 12-year Follow-up Study.
     J Clin Endocrinol Metab. 2023 Aug 10:dgad452. doi: 10.1210.
     PubMed     Abstract available
     
     
     
167. HOU Y, Dai H, Chen N, Zhao Z, et al
     Whole blood-based transcriptional risk score for nonobese type 2 diabetes predicts dynamic changes in glucose metabolism.
     J Clin Endocrinol Metab. 2023 Aug 9:dgad466. doi: 10.1210.
     PubMed     Abstract available
     
     
     
168. FISKER FA, Voss TS, Svart MV, Kampmann U, et al
     Insulin signaling is preserved in skeletal muscle during early diabetic ketoacidosis.
     J Clin Endocrinol Metab. 2023 Aug 9:dgad464. doi: 10.1210.
     PubMed     Abstract available
     
     
     
169. BELLINI S, Guarrera S, Matullo G, Schalkwijk C, et al
     Serum MicroRNA-191-5p Levels in Vascular Complications of Type 1 Diabetes: the EURODIAB Prospective Complications Study.
     J Clin Endocrinol Metab. 2023 Aug 8:dgad468. doi: 10.1210.
     PubMed     Abstract available
     
     
     
170. HARBORG S, Kjaergaard KA, Thomsen RW, Borgquist S, et al
     New Horizons: Epidemiology of Obesity, Diabetes Mellitus, and Cancer Prognosis.
     J Clin Endocrinol Metab. 2023 Aug 8:dgad450. doi: 10.1210.
     PubMed     Abstract available
     
     
     July 2023
171. ZHU Y, Wang H, Ma R, Zhang L, et al
     Association of Gestational Diabetes Mellitus Complicated with Short Sleep Duration and Child Neurodevelopmental Delay.
     J Clin Endocrinol Metab. 2023 Jul 29:dgad446. doi: 10.1210.
     PubMed     Abstract available
     
     
     
172. CERSOSIMO E, Alatrach M, Solis-Herrera C, Gozde B, et al
     Emergence of a New Gluco-Regulatory Mechanism for Glycemic Control with Dapagliflozin/Exenatide Therapy in Type 2 Diabetes.
     J Clin Endocrinol Metab. 2023 Jul 22:dgad438. doi: 10.1210.
     PubMed     Abstract available
     
     
     
173. ETTINGER RA, Buitinga M, Vandamme C, Afonso G, et al
     Technical Validation and Utility of an HLA Class II Tetramer Assay for Type 1 Diabetes: A Multicenter Study.
     J Clin Endocrinol Metab. 2023 Jul 20:dgad434. doi: 10.1210.
     PubMed     Abstract available
     
     
     
174. HARTMANN B, Longo M, Mathiesen DS, Hare KJ, et al
     Signs of a Glucose and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 Diabetes.
     J Clin Endocrinol Metab. 2023 Jul 19:dgad431. doi: 10.1210.
     PubMed     Abstract available
     
     
     
175. KRISTENSEN KB, Ranjan AG, McCarthy OM, Holst JJ, et al
     Effects of a low-carbohydrate-high-protein pre-exercise meal in type 1 diabetes - a randomised, crossover trial.
     J Clin Endocrinol Metab. 2023 Jul 18:dgad427. doi: 10.1210.
     PubMed     Abstract available
     
     
     
176. CHEN JX, Geng T, Zhang YB, Wang Y, et al
     Associations of Clinical Risk Factors and Novel Biomarkers with Age at Onset of Type 2 Diabetes.
     J Clin Endocrinol Metab. 2023 Jul 15:dgad422. doi: 10.1210.
     PubMed     Abstract available
     
     
     
177. CAPPOLA AR, Auchus RJ, El-Hajj Fuleihan G, Handelsman DJ, et al
     Hormones and Aging: An Endocrine Society Scientific Statement.
     J Clin Endocrinol Metab. 2023;108:1835-1874.
     PubMed     Abstract available
     
     
     
178. CHEN X, Ma C, Zhi L, Wei X, et al
     Hemichorea Associated With Nonketotic Hyperglycemia.
     J Clin Endocrinol Metab. 2023;108:e550-e556.
     PubMed     Abstract available
     
     
     
179. WANG X, Zhao C, Feng H, Li G, et al
     Associations of Insomnia With Insulin Resistance Traits: A Cross-sectional and Mendelian Randomization Study.
     J Clin Endocrinol Metab. 2023;108:e574-e582.
     PubMed     Abstract available
     
     
     
180. SMITH K, Taylor GS, Walker M, Brunsgaard LH, et al
     Pre-Meal Whey Protein Alters Postprandial Insulinemia by Enhancing beta-Cell Function and Reducing Insulin Clearance in T2D.
     J Clin Endocrinol Metab. 2023;108:e603-e612.
     PubMed     Abstract available
     
     
     
181. VERNARDIS SI, Demichev V, Lemke O, Gruning NM, et al
     The Impact of Acute Nutritional Interventions on the Plasma Proteome.
     J Clin Endocrinol Metab. 2023;108:2087-2098.
     PubMed     Abstract available
     
     
     
182. QI W, Zhu D, Yin P, Gu X, et al
     Pigment epithelium-derived factor (PEDF), a novel adipokine contributes to gestational diabetes mellitus (GDM).
     J Clin Endocrinol Metab. 2023 Jul 13:dgad413. doi: 10.1210.
     PubMed     Abstract available
     
     
     
183. CHEN R, Armamento-Villareal R
     Obesity and Skeletal Fragility.
     J Clin Endocrinol Metab. 2023 Jul 13:dgad415. doi: 10.1210.
     PubMed     Abstract available
     
     
     
184. HUANG C, Chen L, Li J, Ma J, et al
     Mitochondrial DNA copy number and risk of diabetes mellitus and metabolic syndrome.
     J Clin Endocrinol Metab. 2023 Jul 11:dgad403. doi: 10.1210.
     PubMed     Abstract available
     
     
     
185. GURGOGLIONE FL, Pitocco D, Montone RA, Rinaldi R, et al
     Microvascular complications are associated with coronary collateralization in type 2 diabetes and chronic occlusion.
     J Clin Endocrinol Metab. 2023 Jul 7:dgad396. doi: 10.1210.
     PubMed     Abstract available
     
     
     
186. MUNOZ PENA JM, Cusi K
     Post-Transplant Diabetes Mellitus: Recent Developments in Pharmacological Management of Hyperglycemia.
     J Clin Endocrinol Metab. 2023 Jul 6:dgad395. doi: 10.1210.
     PubMed     Abstract available
     
     
     
187. SUGIMOTO H, Hironaka KI, Yamada T, Sakaguchi K, et al
     DI/cle, a Measure Consisting of Insulin Sensitivity, Secretion, and Clearance, Captures Diabetic States.
     J Clin Endocrinol Metab. 2023 Jul 5:dgad392. doi: 10.1210.
     PubMed     Abstract available
     
     
     June 2023
188. THOGERSEN M, Nielsen KK, Wibaek R, Damm P, et al
     Body mass index trajectories in children exposed to gestational diabetes in utero: a nationwide register-based study.
     J Clin Endocrinol Metab. 2023 Jun 28:dgad384. doi: 10.1210.
     PubMed     Abstract available
     
     
     
189. LU T, Nakanishi T, Yoshiji S, Butler-Laporte G, et al
     Dose-dependent Association of Alcohol Consumption With Obesity and Type 2 Diabetes: Mendelian Randomization Analyses.
     J Clin Endocrinol Metab. 2023 Jun 27:dgad324. doi: 10.1210.
     PubMed     Abstract available
     
     
     
190. OHNO R, Kaneko H, Ueno K, Aoki H, et al
     Association of Body Mass Index and Its Change with Incident Diabetes Mellitus.
     J Clin Endocrinol Metab. 2023 Jun 23:dgad374. doi: 10.1210.
     PubMed     Abstract available
     
     
     
191. GILLIAM-VIGH H, Jorsal T, Nielsen SW, Forman JL, et al
     Expression of Secretin and its Receptor Along the Intestinal Tract in Type 2 Diabetes Patients and Healthy Controls.
     J Clin Endocrinol Metab. 2023 Jun 19:dgad372. doi: 10.1210.
     PubMed     Abstract available
     
     
     
192. SALAMA M, Balagopal B, Fennoy I, Kumar S, et al
     Childhood Obesity, Diabetes and Cardiovascular Disease Risk.
     J Clin Endocrinol Metab. 2023 Jun 16:dgad361. doi: 10.1210.
     PubMed     Abstract available
     
     
     
193. DIAZ-THOMAS AM, Golden SH, Dabelea DM, Grimberg A, et al
     Endocrine Health and Health Care Disparities in the Pediatric and Sexual and Gender Minority Populations: An Endocrine Society Scientific Statement.
     J Clin Endocrinol Metab. 2023;108:1533-1584.
     PubMed     Abstract available
     
     
     
194. SLAGBOOM TNA, van Bunderen CC, van der Lely AJ, Drent ML, et al
     Sex Differences in Long-Term Safety and Tolerability of GH Replacement Therapy in GH Deficient Adults.
     J Clin Endocrinol Metab. 2023;108:e415-e424.
     PubMed     Abstract available
     
     
     
195. BIELINSKI SJ, Yanes Cardozo LL, Takahashi PY, Larson NB, et al
     Predictors of Metformin Failure: Repurposing Electronic Health Record Data to Identify High-Risk Patients.
     J Clin Endocrinol Metab. 2023;108:1740-1746.
     PubMed     Abstract available
     
     
     
196. SADA K, Yoshida Y, Shibuta K, Kimoto K, et al
     Associations of diabetic retinopathy severity with high ambulatory blood pressure and suppressed plasma renin levels.
     J Clin Endocrinol Metab. 2023 Jun 15:dgad358. doi: 10.1210.
     PubMed     Abstract available
     
     
     
197. WANG Q, Chen Y, Xie Y, Xia Y, et al
     Type 2 diabetes family history as a significant index on the clinical heterogeneity differentiation in type 1 diabetes.
     J Clin Endocrinol Metab. 2023 Jun 15:dgad363. doi: 10.1210.
     PubMed     Abstract available
     
     
     
198. RETNAKARAN R, Shah BR
     The Glucose Challenge Test in Pregnancy Identifies Future Risk of Diabetes.
     J Clin Endocrinol Metab. 2023 Jun 15:dgad359. doi: 10.1210.
     PubMed     Abstract available
     
     
     
199. IMAGAWA A, Hanafusa T
     Fulminant type 1 diabetes - East and West.
     J Clin Endocrinol Metab. 2023 Jun 13:dgad329. doi: 10.1210.
     PubMed     Abstract available
     
     
     
200. SIMMONS KM, Sims EK
     Screening and prevention of type 1 diabetes: Where are we?
     J Clin Endocrinol Metab. 2023 Jun 8:dgad328. doi: 10.1210.
     PubMed     Abstract available
     
     
     
201. LIAN H, Gong S, Li M, Wang X, et al
     Prevalence and Clinical Characteristics of PDX1 Variant Induced - Diabetes in Chinese Early Onset Type 2 Diabetes.
     J Clin Endocrinol Metab. 2023 Jun 6:dgad303. doi: 10.1210.
     PubMed     Abstract available
     
     
     
202. YE YX, Wang Y, Wu P, Yang X, et al
     Blood cell parameters from early to middle pregnancy and risk of gestational diabetes mellitus.
     J Clin Endocrinol Metab. 2023 Jun 6:dgad336. doi: 10.1210.
     PubMed     Abstract available
     
     
     
203. INGERSEN A, Schmucker M, Alexandersen C, Graungaard B, et al
     Effects of aerobic training and semaglutide treatment on pancreatic beta-cell secretory function in patients with type 2 diabetes.
     J Clin Endocrinol Metab. 2023 Jun 2:dgad326. doi: 10.1210.
     PubMed     Abstract available
     
     
     May 2023
204. OSORIO-CONLES O, Jimenez A, Ibarzabal A, Balibrea JM, et al
     Limited Bariatric Surgery-induced Weight Loss in Subjects With Type 2 Diabetes: Predictor Variables in Adipose Tissue.
     J Clin Endocrinol Metab. 2023 May 30:dgad271. doi: 10.1210.
     PubMed     Abstract available
     
     
     
205. GIANDALIA A, Russo GT, Ruggeri P, Giancaterini A, et al
     The burden of obesity in type 1 diabetic subjects: a sex-specific analysis from the AMD Annals Initiative.
     J Clin Endocrinol Metab. 2023 May 29:dgad302. doi: 10.1210.
     PubMed     Abstract available
     
     
     
206. GERSZI D, Orosz G, Torok M, Szalay B, et al
     Risk estimation of gestational diabetes mellitus in the first trimester.
     J Clin Endocrinol Metab. 2023 May 29:dgad301. doi: 10.1210.
     PubMed     Abstract available
     
     
     
207. POKHAREL P, Bellinge JW, Dalgaard F, Murray K, et al
     Vitamin K1 intake and incident diabetes in the Danish Diet Cancer and Health Study.
     J Clin Endocrinol Metab. 2023 May 26:dgad293. doi: 10.1210.
     PubMed     Abstract available
     
     
     
208. CHIEN WC, Fu E, Chung CH, Cheng CM, et al
     Type 2 diabetes mellitus and periodontitis: Bi-directional association in population-based 15-year retrospective cohorts.
     J Clin Endocrinol Metab. 2023 May 24:dgad287. doi: 10.1210.
     PubMed     Abstract available
     
     
     
209. SORMUNEN-HARJU H, Huvinen E, Girchenko PV, Kajantie E, et al
     Metabolomic Profiles of Nonobese and Obese Women With Gestational Diabetes.
     J Clin Endocrinol Metab. 2023 May 23:dgad288. doi: 10.1210.
     PubMed     Abstract available
     
     
     
210. URRUTIA I, Martinez R, Calvo B, Saso-Jimenez L, et al
     Autoimmune Diabetes From Chilhood to Adulthood: The Role of Pancreatic Autoantibodies and Hla-Drb1 Genotype.
     J Clin Endocrinol Metab. 2023 May 19:dgad277. doi: 10.1210.
     PubMed     Abstract available
     
     
     
211. KIM SH, Arora I, Hsia DS, Knowler WC, et al
     New-Onset Diabetes after COVID-19.
     J Clin Endocrinol Metab. 2023 May 19:dgad284. doi: 10.1210.
     PubMed     Abstract available
     
     
     
212. HOCKETT CW, Harrall KK, Glueck DH, Dabelea DM, et al
     Exposure to gestational diabetes and BMI trajectories through adolescence: Exploring Perinatal Outcomes in Children study.
     J Clin Endocrinol Metab. 2023 May 18:dgad278. doi: 10.1210.
     PubMed     Abstract available
     
     
     
213. LIU CT, Tsai T, Allaire BT, Bouxsein ML, et al
     Accumulation in Visceral Adipose Tissue Over 6 Years Is Associated With Lower Paraspinal Muscle Density.
     J Clin Endocrinol Metab. 2023;108:1348-1354.
     PubMed     Abstract available
     
     
     
214. WRIGHT JJ, Johnson DB
     Approach to the Patient With Immune Checkpoint Inhibitor-Associated Endocrine Dysfunction.
     J Clin Endocrinol Metab. 2023;108:1514-1525.
     PubMed     Abstract available
     
     
     
215. YE W, Xu L, Ye Y, Zeng F, et al
     The efficacy and safety of meal replacement in patients with type 2 diabetes: a systematic review and meta-analysis.
     J Clin Endocrinol Metab. 2023 May 16:dgad273. doi: 10.1210.
     PubMed     Abstract available
     
     
     
216. ZHANG M, Zucatti KP, Teixeira PP, Spiazzi BF, et al
     Response to Letter to the Editor from Stumpf et al.: Cancer Outcomes Among Prediabetes and Type 2 Diabetes Populations With Dietary and Physical Activity-based Lifestyle Interventions.
     J Clin Endocrinol Metab. 2023 May 12:dgad266. doi: 10.1210.
     PubMed    
     
     
     
217. ELEFTHERIOU A, Ong KK, Hughes IA, Petry CJ, et al
     Leptin and IGF-1 in infancy are associated with variants in DHCR7 and CYP2R1 that relate with type 1 diabetes and 25OHD.
     J Clin Endocrinol Metab. 2023 May 12:dgad263. doi: 10.1210.
     PubMed     Abstract available
     
     
     
218. STUMPF MAM, Mancini MC, Cercato C, de Melo ME, et al
     Letter to the Editor from Stumpf et al.: Cancer Outcomes among Prediabetes and Type 2 Diabetes Populations with Dietary and Physical Activity-Based Lifestyle Interventions.
     J Clin Endocrinol Metab. 2023 May 12:dgad265. doi: 10.1210.
     PubMed    
     
     
     
219. VERHOEFF K, Marfil-Garza BA, Czarnecka Z, Cuesta-Gomez N, et al
     Stem Cell-Derived Islet Transplantation in Patients with Type 2 Diabetes: Can Diabetes Subtypes Guide Implementation?
     J Clin Endocrinol Metab. 2023 May 12:dgad257. doi: 10.1210.
     PubMed     Abstract available
     
     
     
220. WANG W, Li N, Wang X, Zhang X, et al
     Remnant cholesterol is associated with gestational diabetes mellitus: a cohort study.
     J Clin Endocrinol Metab. 2023 May 11:dgad262. doi: 10.1210.
     PubMed     Abstract available
     
     
     
221. MEIER C, Eastell R, Pierroz DD, Lane NE, et al
     Biochemical Markers of Bone Fragility in Patients with Diabetes. A Narrative Review by the IOF and the ECTS.
     J Clin Endocrinol Metab. 2023 May 8:dgad255. doi: 10.1210.
     PubMed     Abstract available
     
     
     
222. 
     Correction to "A Reduced Pancreatic Polypeptide Response is Associated With New-onset Pancreatogenic Diabetes Versus Type 2 Diabetes".
     J Clin Endocrinol Metab. 2023 May 8:dgad241. doi: 10.1210.
     PubMed    
     
     
     
223. MEIER C, Eastell R, Pierroz DD, Lane NE, et al
     Biochemical Markers of Bone Fragility in Patients With Diabetes.
     J Clin Endocrinol Metab. 2023 May 8:dgad255. doi: 10.1210.
     PubMed     Abstract available
     
     
     
224. BORISOV AN, Kutz A, Christ ER, Heim MH, et al
     Canagliflozin and Metabolic Associated Fatty Liver Disease in Patients with Diabetes Mellitus: New Insights from CANVAS.
     J Clin Endocrinol Metab. 2023 May 7:dgad249. doi: 10.1210.
     PubMed     Abstract available
     
     
     
225. VAN DER VAART A, Eelderink C, van Beek AP, Bakker SJL, et al
     Fibroblast growth factor 23, glucose homeostasis and incident diabetes: findings of two cohort studies.
     J Clin Endocrinol Metab. 2023 May 4:dgad246. doi: 10.1210.
     PubMed     Abstract available
     
     
     April 2023
226. 
     Correction to "beta-Cell Function and Insulin Sensitivity in Youth With Early Type 1 Diabetes From a 2-Hour 7-Sample OGTT".
     J Clin Endocrinol Metab. 2023 Apr 25:dgad221. doi: 10.1210.
     PubMed    
     
     
     
227. WU HX, Chu TY, Iqbal J, Jiang HL, et al
     Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study.
     J Clin Endocrinol Metab. 2023 Apr 24:dgad233. doi: 10.1210.
     PubMed     Abstract available
     
     
     
228. KIANERSI S, Redline S, Mongraw-Chaffin M, Huang T, et al
     Associations of slow-wave sleep with prevalent and incident type 2 diabetes in The Multi-Ethnic Study of Atherosclerosis.
     J Clin Endocrinol Metab. 2023 Apr 21:dgad229. doi: 10.1210.
     PubMed     Abstract available
     
     
     
229. WANG C, Xin Q, Zheng M, Liu S, et al
     Association of Resting Heart Rate Trajectories with Cardiovascular Disease and Mortality in Diabetes Mellitus Patients.
     J Clin Endocrinol Metab. 2023 Apr 21:dgad228. doi: 10.1210.
     PubMed     Abstract available
     
     
     
230. ZHUANG Z, Dong X, Jia J, Liu Z, et al
     Sleep patterns, plasma metabolome and risk of incident type 2 diabetes.
     J Clin Endocrinol Metab. 2023 Apr 21:dgad218. doi: 10.1210.
     PubMed     Abstract available
     
     
     
231. DIAZ-BALZAC CA, Pillinger D, Wittlin SD
     Continuous Subcutaneous Insulin Infusions: Closing the Loop.
     J Clin Endocrinol Metab. 2023;108:1019-1033.
     PubMed     Abstract available
     
     
     
232. SOMMER C, Vangberg KG, Moen GH, Evans DM, et al
     Insulin and Body Mass Index Decrease Serum Soluble Leptin Receptor Levels in Humans.
     J Clin Endocrinol Metab. 2023;108:1110-1119.
     PubMed     Abstract available
     
     
     
233. SONG R, Hu W, Cheng R, Zhao Y, et al
     Association between circulating levels of C1q/TNF-Related Protein-9 and type 2 diabetes mellitus: a systematic review and meta-analysis.
     J Clin Endocrinol Metab. 2023 Apr 8:dgad172. doi: 10.1210.
     PubMed     Abstract available
     
     
     
234. HSIAO FC, Chan YH, Tung YC, Lin CP, et al
     Visit-to-visit hemoglobin A1c variation and long-term risk of major adverse limb events in patients with type 2 diabetes.
     J Clin Endocrinol Metab. 2023 Apr 6:dgad203. doi: 10.1210.
     PubMed     Abstract available
     
     
     
235. WANG K, Ahmadizar F, Geurts S, Arshi B, et al
     Heart rate variability and incident type 2 diabetes in general population.
     J Clin Endocrinol Metab. 2023 Apr 6:dgad200. doi: 10.1210.
     PubMed     Abstract available
     
     
     
236. GAN L, Li N, Heizhati M, Li M, et al
     Diurnal cortisol features with type 2 diabetes in patients with hypertension and obstructive sleep apnea: a cohort study.
     J Clin Endocrinol Metab. 2023 Apr 6:dgad184. doi: 10.1210.
     PubMed     Abstract available
     
     
     
237. MILLOH-RAZ H, Twig G
     Protecting the Brain of People with Type 2 Diabetes.
     J Clin Endocrinol Metab. 2023 Apr 3:dgad191. doi: 10.1210.
     PubMed    
     
     
     
238. DERELLA CC, Thomas J, Harris RA
     Women Have Greater Endothelin-B Receptor Function and Lower Mitochondrial Capacity Compared to Men with Type 1 Diabetes.
     J Clin Endocrinol Metab. 2023 Apr 3:dgad189. doi: 10.1210.
     PubMed     Abstract available
     
     
     
239. REN Q, Wang Z, Yang W, Han X, et al
     The maternal and infant outcomes in GCK-MODY complicated with pregnancy: Systemic review and meta-analysis.
     J Clin Endocrinol Metab. 2023 Apr 3:dgad188. doi: 10.1210.
     PubMed     Abstract available
     
     
     March 2023
240. ZHANG S, Li S, Huang J, Ding X, et al
     Gram-negative bacteria and lipopolysaccharides as risk factors for the occurrence of diabetic foot.
     J Clin Endocrinol Metab. 2023 Mar 28:dgad178. doi: 10.1210.
     PubMed     Abstract available
     
     
     
241. SATO T, Azuma Y, Ozone C, Okazaki M, et al
     Possible Advantage of Glucagon-Like Peptide 1 Receptor Agonists for Kidney Transplant Recipients With Type 2 Diabetes.
     J Clin Endocrinol Metab. 2023 Mar 28:dgad177. doi: 10.1210.
     PubMed     Abstract available
     
     
     
242. WHITE SL, Koulman A, Ozanne SE, Furse S, et al
     Towards precision medicine in gestational diabetes: pathophysiology and glycemic patterns in pregnant women with obesity.
     J Clin Endocrinol Metab. 2023 Mar 23:dgad168. doi: 10.1210.
     PubMed     Abstract available
     
     
     
243. WANG Y, Guo H, Wang G, Zhai J, et al
     COVID-19 as a Trigger for type 1 diabetes.
     J Clin Endocrinol Metab. 2023 Mar 23:dgad165. doi: 10.1210.
     PubMed     Abstract available
     
     
     
244. JACK GA, Kashyap SR
     "Insulin independence with SGLT2 inhibitor use in Type 2 Diabetes".
     J Clin Endocrinol Metab. 2023 Mar 22:dgad143. doi: 10.1210.
     PubMed    
     
     
     
245. PAPADOPOULOU A, Thymara E, Maratou E, Kanellopoulos G, et al
     Human placental LRP5 and Sclerostin are increased in gestational diabetes mellitus pregnancies.
     J Clin Endocrinol Metab. 2023 Mar 22:dgad164. doi: 10.1210.
     PubMed     Abstract available
     
     
     
246. WRIGHT JJ, Dulaney A, Williams JM, Hilmes MA, et al
     Longitudinal MRI Shows Progressive Decline in Pancreas Size and Altered Pancreas Shape in Type 1 Diabetes.
     J Clin Endocrinol Metab. 2023 Mar 20:dgad150. doi: 10.1210.
     PubMed     Abstract available
     
     
     
247. OIWA A, Hiwatashi D, Takeda T, Miyamoto T, et al
     Efficacy and safety of low-dose spironolactone for chronic kidney disease in type 2 diabetes.
     J Clin Endocrinol Metab. 2023 Mar 14:dgad144. doi: 10.1210.
     PubMed     Abstract available
     
     
     
248. MIKLOSZ A, Chabowski A
     Adipose-derived mesenchymal stem cells therapy as a new treatment option for diabetes mellitus.
     J Clin Endocrinol Metab. 2023 Mar 14:dgad142. doi: 10.1210.
     PubMed     Abstract available
     
     
     
249. GILLIAM-VIGH H, Jorsal T, Nielsen SW, Forman JL, et al
     Expression of Neurotensin and its Receptors Along the Intestinal Tract in Type 2 Diabetes Patients and Healthy Controls.
     J Clin Endocrinol Metab. 2023 Mar 14:dgad146. doi: 10.1210.
     PubMed     Abstract available
     
     
     
250. YE J, Guo K, Li X, Yang L, et al
     The prevalence of metabolically unhealthy normal weight and its influence on the risk of diabetes.
     J Clin Endocrinol Metab. 2023 Mar 14:dgad152. doi: 10.1210.
     PubMed     Abstract available
     
     
     
251. LI G, Jankowich MD, Lu Y, Wu L, et al
     Preserved Ratio Impaired Spirometry, Metabolomics and the Risk of Type 2 Diabetes.
     J Clin Endocrinol Metab. 2023 Mar 10:dgad140. doi: 10.1210.
     PubMed     Abstract available
     
     
     
252. AMARIKWA L, Mohamed A, Kim SH, Kossler AL, et al
     Teprotumumab-Related Hyperglycemia.
     J Clin Endocrinol Metab. 2023;108:858-864.
     PubMed     Abstract available
     
     
     
253. HERRING RA, Parsons I, Shojaee-Moradie F, Stevenage M, et al
     Effect of Dapagliflozin on Cardiac Function and Metabolic and Hormonal Responses to Exercise.
     J Clin Endocrinol Metab. 2023;108:888-896.
     PubMed     Abstract available
     
     
     
254. SANDERS WM, Harlow SD, Ylitalo KR, Lange-Maia BS, et al
     The Association of Inflammatory Factors With Peripheral Neuropathy: The Study of Women's Health Across the Nation.
     J Clin Endocrinol Metab. 2023;108:962-970.
     PubMed     Abstract available
     
     
     
255. DEI CAS A, Aldigeri R, Mantovani A, Masulli M, et al
     Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes.
     J Clin Endocrinol Metab. 2023 Mar 7:dgad127. doi: 10.1210.
     PubMed     Abstract available
     
     
     
256. ALLOQI TAHIRBEGOLLI I, Tahirbegolli B, Sen S, Sayin B, et al
     Evaluation of Stress Response in Middle Age Male Diabetic Hypertensive Patients.
     J Clin Endocrinol Metab. 2023 Mar 6:dgad122. doi: 10.1210.
     PubMed     Abstract available
     
     
     
257. SONG Q, Zhou T, Chen S, Liao Y, et al
     Association of gestational diabetes with the dynamic changes of gut microbiota in offspring from 1 to 6 months of age.
     J Clin Endocrinol Metab. 2023 Mar 4:dgad107. doi: 10.1210.
     PubMed     Abstract available
     
     
     
258. ZHANG M, Zucatti KP, Teixeira PP, Correia PE, et al
     Cancer outcomes among prediabetes and type 2 diabetes populations with dietary and physical activity-based lifestyle interventions: A systematic review and meta-analysis.
     J Clin Endocrinol Metab. 2023 Mar 3:dgad123. doi: 10.1210.
     PubMed     Abstract available
     
     
     February 2023
259. MUKHOPADHYAY P, Sanyal D, Chatterjee P, Pandit K, et al
     SGLT2 inhibitors: Effect on myocardial infarction and stroke in type 2 diabetes.
     J Clin Endocrinol Metab. 2023 Feb 28:dgad113. doi: 10.1210.
     PubMed     Abstract available
     
     
     
260. LEE CH, Lui DT, Cheung CY, Fong CH, et al
     Circulating AFABP, FGF21 and PEDF levels as prognostic biomarkers of sight-threatening diabetic retinopathy.
     J Clin Endocrinol Metab. 2023 Feb 28:dgad112. doi: 10.1210.
     PubMed     Abstract available
     
     
     
261. BANERJEE M, Pal R, Mukhopadhyay S, Nair K, et al
     GLP-1 Receptor Agonists and Risk of Adverse Cerebrovascular Outcomes in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
     J Clin Endocrinol Metab. 2023 Feb 17:dgad076. doi: 10.1210.
     PubMed     Abstract available
     
     
     
262. AJIE M, van Heck JIP, Janssen AWM, Meijer RI, et al
     Disease duration and chronic complications associate with immune activation in individuals with longstanding type 1 diabetes.
     J Clin Endocrinol Metab. 2023 Feb 17:dgad087. doi: 10.1210.
     PubMed     Abstract available
     
     
     
263. FRIDELL JA, Stratta RJ, Gruessner AC
     Pancreas Transplantation: Current Challenges, Considerations, and Controversies.
     J Clin Endocrinol Metab. 2023;108:614-623.
     PubMed     Abstract available
     
     
     
264. LIU Y, Ping F, Yu J, Lv L, et al
     Hypoglycemia Caused by Exogenous Insulin Antibody Syndrome: A Large Single-Center Case Series From China.
     J Clin Endocrinol Metab. 2023;108:713-717.
     PubMed     Abstract available
     
     
     
265. MCDONNELL ME, Garg R, Gopalakrishnan G, Mitri J, et al
     Glycemic Gap Predicts Mortality in a Large Multicenter Cohort Hospitalized With COVID-19.
     J Clin Endocrinol Metab. 2023;108:718-725.
     PubMed     Abstract available
     
     
     
266. PENG MQ, Karvonen-Gutierrez CA, Herman WH, Mukherjee B, et al
     Phthalates and Incident Diabetes in Midlife Women: The Study of Women's Health Across the Nation (SWAN).
     J Clin Endocrinol Metab. 2023 Feb 8:dgad033. doi: 10.1210.
     PubMed     Abstract available
     
     
     
267. 
     Correction to "Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline".
     J Clin Endocrinol Metab. 2023 Feb 8:dgad065. doi: 10.1210.
     PubMed    
     
     
     
268. NWOKOLO M, Hovorka R
     The Artificial Pancreas and Type 1 Diabetes.
     J Clin Endocrinol Metab. 2023 Feb 3:dgad068. doi: 10.1210.
     PubMed     Abstract available
     
     
     
269. WU S, Li L, Hu KL, Wang S, et al
     A Prediction Model of Gestational Diabetes Mellitus Based on OGTT in Early Pregnancy: A Prospective Cohort Study.
     J Clin Endocrinol Metab. 2023 Feb 1:dgad052. doi: 10.1210.
     PubMed     Abstract available
     
     
     January 2023
270. WEI Y, Wang R, Wang J, Han X, et al
     Transitions in metabolic health status and obesity over time and risk of diabetes: the Dongfeng-Tongji cohort study.
     J Clin Endocrinol Metab. 2023 Jan 31:dgad047. doi: 10.1210.
     PubMed     Abstract available
     
     
     
271. NASSER MI, Stidsen JV, Hojlund K, Nielsen JS, et al
     Low Bone Turnover Associates with Lower Insulin Sensitivity in Newly Diagnosed Drug-naive Persons with Type 2 Diabetes.
     J Clin Endocrinol Metab. 2023 Jan 31:dgad043. doi: 10.1210.
     PubMed     Abstract available
     
     
     
272. KOMMAREDDI M, Wherry K, Vigersky RA
     Racial/Ethnic Inequities in Use of Diabetes Technologies Among Medicare Advantage Beneficiaries with Type 1 Diabetes.
     J Clin Endocrinol Metab. 2023 Jan 30:dgad046. doi: 10.1210.
     PubMed     Abstract available
     
     
     
273. DAGOGO-JACK S, Frederich R, Liu J, Cannon CP, et al
     Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV.
     J Clin Endocrinol Metab. 2023 Jan 26:dgac764. doi: 10.1210.
     PubMed     Abstract available
     
     
     
274. FAHRNER A, Laiferova NA, Ukropcova B, Ukropec J, et al
     Activation of PDGF signaling in the adult muscle stem cell niche in patients with type 2 diabetes mellitus.
     J Clin Endocrinol Metab. 2023 Jan 26:dgad041. doi: 10.1210.
     PubMed     Abstract available
     
     
     
275. SIEGELAAR SE, de Galan BE
     Resistance training, a strong case for people with type 1 diabetes?
     J Clin Endocrinol Metab. 2023 Jan 24:dgad037. doi: 10.1210.
     PubMed    
     
     
     
276. 
     Correction to: "GLP-1 Receptor Agonists and SGLT-2 Inhibitors as Adjuncts to Insulin in Type 1 Diabetes: Benefits and Concerns".
     J Clin Endocrinol Metab. 2023 Jan 19:dgad022. doi: 10.1210.
     PubMed    
     
     
     
277. XIA Y, Chen Y, Li X, Luo S, et al
     HLA Class I association with autoimmune diabetes in Chinese: Distinct implications in classic type 1 diabetes and LADA.
     J Clin Endocrinol Metab. 2023 Jan 18:dgad006. doi: 10.1210.
     PubMed     Abstract available
     
     
     
278. QI L, Chen Y
     Circulating Bile Acids as Biomarkers for Disease Diagnosis and Prevention.
     J Clin Endocrinol Metab. 2023;108:251-270.
     PubMed     Abstract available
     
     
     
279. BELFORT-DEAGUIAR R, Lomonaco R, Cusi K
     Approach to the Patient With Nonalcoholic Fatty Liver Disease.
     J Clin Endocrinol Metab. 2023;108:483-495.
     PubMed     Abstract available
     
     
     
280. HIGASHIOKA M, Hirakawa Y, Hata J, Honda T, et al
     Serum Mac-2 binding protein glycosylation isomer concentrations are associated with incidence of type 2 diabetes.
     J Clin Endocrinol Metab. 2023 Jan 13:dgad011. doi: 10.1210.
     PubMed     Abstract available
     
     
     
281. HORTON WB, Snell-Bergeon JK
     HbA1c Variability Metrics Predict Coronary Artery Calcium and Cardiovascular Events in Type 1 Diabetes: the CACTI Study.
     J Clin Endocrinol Metab. 2023 Jan 13:dgad019. doi: 10.1210.
     PubMed     Abstract available
     
     
     
282. PERSKY V, Abasilim C, Tsintsifas K, Day T, et al
     Sex Hormones and Diabetes in 45-74-Year- Old Men and Postmenopausal Women: the Hispanic Community Health Study.
     J Clin Endocrinol Metab. 2023 Jan 12:dgad018. doi: 10.1210.
     PubMed     Abstract available
     
     
     
283. BOYLE JG, Lean MEJ
     Type 2 diabetes remission: achieving calorie restriction and weight loss by any which way?
     J Clin Endocrinol Metab. 2023 Jan 6:dgac755. doi: 10.1210.
     PubMed    
     
     
     
284. ALHAMAR G, Briganti S, Maggi D, Viola V, et al
     Pre-vaccination glucose time in range correlates with antibody response to SARS-CoV-2 vaccine in type 1 diabetes.
     J Clin Endocrinol Metab. 2023 Jan 6:dgad001. doi: 10.1210.
     PubMed     Abstract available
     
     
     
285. YUE C, Ying C, Li X
     Elevated serum uric acid is associated with gestational diabetes mellitus: an observational cohort study.
     J Clin Endocrinol Metab. 2023 Jan 2:dgac760. doi: 10.1210.
     PubMed     Abstract available
     
     
     December 2022
286. ECHOUFFO-TCHEUGUI J
     Does the duration of diabetes matter when evaluating the risk of heart failure?
     J Clin Endocrinol Metab. 2022 Dec 31:dgac761. doi: 10.1210.
     PubMed    
     
     
     
287. 
     Correction to "Altered Intrinsic Brain Activity Related to Neurologic and Motor Dysfunction in Diabetic Peripheral Neuropathy Patients".
     J Clin Endocrinol Metab. 2022 Dec 30:dgac749. doi: 10.1210.
     PubMed    
     
     
     
288. JIANG W, Zhang J, Yang R, Sun X, et al
     Association of urinary nitrate with diabetes complication and disease-specific mortality among adults with hyperglycemia.
     J Clin Endocrinol Metab. 2022 Dec 28:dgac741. doi: 10.1210.
     PubMed     Abstract available
     
     
     
289. GENG T, Chen JX, Zhou YF, Lu Q, et al
     Proton Pump Inhibitor Use and Risks of Cardiovascular Disease and Mortality in Patients with Type 2 Diabetes.
     J Clin Endocrinol Metab. 2022 Dec 27:dgac750. doi: 10.1210.
     PubMed     Abstract available
     
     
     
290. LEE HS, Chae W, Sung MJ, Keum J, et al
     Difference of risk of pancreatic cancer in new-onset diabetes and long-standing diabetes: population-based cohort study.
     J Clin Endocrinol Metab. 2022 Dec 22:dgac728. doi: 10.1210.
     PubMed     Abstract available
     
     
     
291. 
     Correction to: "Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline".
     J Clin Endocrinol Metab. 2022 Dec 22:dgac737. doi: 10.1210.
     PubMed    
     
     
     
292. GALDERISI A, Evans-Molina C, Martino M, Caprio S, et al
     Beta cell function and insulin sensitivity in youth with early type 1 diabetes from a two-hour 7-sample OGTT.
     J Clin Endocrinol Metab. 2022 Dec 21:dgac740. doi: 10.1210.
     PubMed     Abstract available
     
     
     
293. POST A, Dam WA, Sokooti S, Groothof D, et al
     Circulating FGF21 Concentration, Fasting Plasma Glucose and the Risk of Type 2 Diabetes: Results from the PREVEND study.
     J Clin Endocrinol Metab. 2022 Dec 19:dgac729. doi: 10.1210.
     PubMed     Abstract available
     
     
     
294. WEJAPHIKUL K, Srilanchakon K, Kamolvisit W, Jantasuwan S, et al
     Novel Variants and Phenotypes in NEUROG3-Associated Syndrome.
     J Clin Endocrinol Metab. 2022;108:52-58.
     PubMed     Abstract available
     
     
     
295. BRIL F, Pearce RW, Collier TS, McPhaul MJ, et al
     Differences in HDL-Bound Apolipoproteins in Patients With Advanced Liver Fibrosis Due to Nonalcoholic Fatty Liver Disease.
     J Clin Endocrinol Metab. 2022;108:42-51.
     PubMed     Abstract available
     
     
     
296. MAHMOUDIEH L, Amiri M, Rahmati M, Habibi Moeini AS, et al
     Idiopathic Hirsutism and Metabolic Status: A Population-based Prospective Cohort Study.
     J Clin Endocrinol Metab. 2022;108:114-123.
     PubMed     Abstract available
     
     
     
297. YANG X, Zhou J, Shao H, Huang B, et al
     Effect of an Intermittent Calorie-restricted Diet on Type 2 Diabetes Remission: A Randomized Controlled Trial.
     J Clin Endocrinol Metab. 2022 Dec 14:dgac661. doi: 10.1210.
     PubMed     Abstract available
     
     
     
298. DIMITRIADIS GD, Lambadiari V
     GLP-1 receptor agonists and SGLT-2 inhibitors as adjuncts to insulin in Type 1 diabetes: benefits and concerns.
     J Clin Endocrinol Metab. 2022 Dec 12:dgac704. doi: 10.1210.
     PubMed    
     
     
     
299. MONGRAW-CHAFFIN M, Tjaden AH, Seals AL, Miller K, et al
     Association of Obesity and Diabetes with SARS-Cov-2 Infection and Symptoms in the COVID-19 Community Research Partnership.
     J Clin Endocrinol Metab. 2022 Dec 9:dgac715. doi: 10.1210.
     PubMed     Abstract available
     
     
     
300. QI Y, Chen S, Chen H, Chen Y, et al
     Combined detection of islet autoantibodies for clinical diagnosis of type 1 diabetes in the low-prevalence population.
     J Clin Endocrinol Metab. 2022 Dec 8:dgac720. doi: 10.1210.
     PubMed     Abstract available
     
     
     
301. FLOWERS E, Aouizerat BE, Kanaya AM, Florez JC, et al
     MicroRNAs Associated with Incident Diabetes in the Diabetes Prevention Program.
     J Clin Endocrinol Metab. 2022 Dec 8:dgac714. doi: 10.1210.
     PubMed     Abstract available
     
     
     
302. HAN Q, Xu H
     Letter to the Editor from Han and Xu "Association between DPP4 inhibitor use and the incidence of cirrhosis, ESRD, and some cancers in patients with diabetes".
     J Clin Endocrinol Metab. 2022 Dec 8:dgac693. doi: 10.1210.
     PubMed    
     
     
     
303. LEE DH
     "Response to Letter to the Editor from Han and Xu: Association between DPP4 inhibitor use and the incidence of cirrhosis, ESRD, and some cancers in patients with diabetes".
     J Clin Endocrinol Metab. 2022 Dec 7:dgac697. doi: 10.1210.
     PubMed    
     
     
     
304. TORRES ROLDAN VD, Urtecho M, Nayfeh T, Firwana M, et al
     A Systematic Review Supporting the Endocrine Society Guidelines: Management of Diabetes and High Risk of Hypoglycemia.
     J Clin Endocrinol Metab. 2022 Dec 7:dgac601. doi: 10.1210.
     PubMed     Abstract available
     
     
     
305. MCCALL AL, Lieb DC, Gianchandani R, MacMaster H, et al
     Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline.
     J Clin Endocrinol Metab. 2022 Dec 7:dgac596. doi: 10.1210.
     PubMed     Abstract available
     
     
     
306. BANCKS MP, Lovato J, Balasubramanyam A, Coday M, et al
     Association of type 2 diabetes subgroups with cognitive status without modification from lifestyle intervention.
     J Clin Endocrinol Metab. 2022 Dec 6:dgac706. doi: 10.1210.
     PubMed     Abstract available
     
     
     
307. CAI J, Yang Q, Lu J, Shen Y, et al
     Impact of the complexity of glucose time series on all-cause mortality in patients with type 2 diabetes.
     J Clin Endocrinol Metab. 2022 Dec 2:dgac692. doi: 10.1210.
     PubMed     Abstract available
     
     
     
308. PERRY AS, Annis JS, Master H, Nayor M, et al
     Association of longitudinal activity measures and diabetes risk: an analysis from the NIH All of Us Research Program.
     J Clin Endocrinol Metab. 2022 Dec 2:dgac695. doi: 10.1210.
     PubMed     Abstract available
     
     
     
309. SIGAL RJ, Yardley JE, Perkins BA, Riddell MC, et al
     The Resistance Exercise in Already Active Diabetic Individuals (READI) Randomised Clinical Trial.
     J Clin Endocrinol Metab. 2022 Dec 2:dgac682. doi: 10.1210.
     PubMed     Abstract available
     
     
     November 2022
310. SHAH RD, Chernausek SD, El Ghormli L, Geffner ME, et al
     Maternal Diabetes in Youth-Onset Type 2 Diabetes Is Associated with Progressive Dysglycemia and Risk of Complications.
     J Clin Endocrinol Metab. 2022 Nov 30:dgac663. doi: 10.1210.
     PubMed     Abstract available
     
     
     
311. LI HL, Tse YK, Chandramouli C, Hon NW, et al
     Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Pneumonia and Septic Shock.
     J Clin Endocrinol Metab. 2022;107:3442-3451.
     PubMed     Abstract available
     
     
     
312. HEIMBURGER SMN, Hoe B, Nielsen CN, Bergman NC, et al
     GIP Affects Hepatic Fat and Brown Adipose Tissue Thermogenesis but Not White Adipose Tissue Transcriptome in Type 1 Diabetes.
     J Clin Endocrinol Metab. 2022;107:3261-3274.
     PubMed     Abstract available
     
     
     
313. NIWANO F, Babaya N, Hiromine Y, Matsumoto I, et al
     Three-Year Observation of Glucose Metabolism After Pancreaticoduodenectomy: A Single-Center Prospective Study in Japan.
     J Clin Endocrinol Metab. 2022;107:3362-3369.
     PubMed     Abstract available
     
     
     
314. VAZQUEZ ARREOLA E, Knowler WC, Hanson RL
     Weight Loss, Lifestyle Intervention, and Metformin Affect Longitudinal Relationship of Insulin Secretion and Sensitivity.
     J Clin Endocrinol Metab. 2022;107:3086-3099.
     PubMed     Abstract available
     
     
     
315. TRAN DT, Pottekat A, Lee K, Raghunathan M, et al
     Inflammatory Cytokines Rewire the Proinsulin Interaction Network in Human Islets.
     J Clin Endocrinol Metab. 2022;107:3100-3110.
     PubMed     Abstract available
     
     
     
316. HART PA, Kudva YC, Yadav D, Andersen DK, et al
     A reduced pancreatic polypeptide response is associated with new onset pancreatogenic diabetes versus type 2 diabetes.
     J Clin Endocrinol Metab. 2022 Nov 21:dgac670. doi: 10.1210.
     PubMed     Abstract available
     
     
     
317. HIRSCHBERG AL
     Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
     J Clin Endocrinol Metab. 2022 Nov 21:dgac673. doi: 10.1210.
     PubMed     Abstract available
     
     
     
318. JUN JE, Lee SE, Lee YB, Kim G, et al
     Low skeletal muscle mass Accompanied by Abdominal Obesity Additively Increases the Risk of Incident Type 2 Diabetes.
     J Clin Endocrinol Metab. 2022 Nov 17. pii: 6832144. doi: 10.1210.
     PubMed     Abstract available
     
     
     
319. YANG HH, Li FR, Chen ZK, Zhou MG, et al
     Duration of Diabetes, Glycemic Control, and Risk of Heart Failure Among Adults With Diabetes: A Cohort Study.
     J Clin Endocrinol Metab. 2022 Nov 16. pii: 6831201. doi: 10.1210.
     PubMed     Abstract available
     
     
     
320. KALAVALAPALLI S, Leiva EG, Lomonaco R, Chi X, et al
     Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients with Type 2 Diabetes and NAFLD.
     J Clin Endocrinol Metab. 2022 Nov 16. pii: 6828054. doi: 10.1210.
     PubMed     Abstract available
     
     
     
321. YE C, Kong L, Wang Y, Lin H, et al
     Causal associations between age at diagnosis of diabetes and cardiovascular outcomes: a Mendelian randomization study.
     J Clin Endocrinol Metab. 2022 Nov 14. pii: 6825732. doi: 10.1210.
     PubMed     Abstract available
     
     
     
322. ARIMA H, Cheetham T, Christ-Crain M, Cooper D, et al
     Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus.
     J Clin Endocrinol Metab. 2022 Nov 9. pii: 6820279. doi: 10.1210.
     PubMed     Abstract available
     
     
     
323. XIN H, Fu Y, Feng M, Wang S, et al
     Altered Intrinsic Brain Activity Related to Neurologic and Motor Dysfunction in Diabetic Peripheral Neuropathy Patients.
     J Clin Endocrinol Metab. 2022 Nov 5. pii: 6803099. doi: 10.1210.
     PubMed     Abstract available
     
     
     
324. WEIR GC
     Islet inflammation can be linked to the disruption of proinsulin processing in type 1 diabetes but not in type 2 diabetes.
     J Clin Endocrinol Metab. 2022 Nov 1. pii: 6785917. doi: 10.1210.
     PubMed    
     
     
     
325. BHADADA SK, Malhotra B, Shetty AJ
     Body weight variability and cardiovascular health in diabetes.
     J Clin Endocrinol Metab. 2022 Nov 1. pii: 6785762. doi: 10.1210.
     PubMed    
     
     
     October 2022
326. PARIKH HM, Remedios CL, Hampe CS, Balasubramanyam A, et al
     Data Mining Framework For Discovering and Clustering Phenotypes of Atypical Diabetes.
     J Clin Endocrinol Metab. 2022 Oct 31. pii: 6782122. doi: 10.1210.
     PubMed     Abstract available
     
     
     
327. DUTTA D, Khandelwal D
     Lifestyle interventions reduce the risk of type-2 diabetes through decreasing branched-chain amino acids: newer insights.
     J Clin Endocrinol Metab. 2022 Oct 28. pii: 6776202. doi: 10.1210.
     PubMed    
     
     
     
328. EDWARDS K, Li X, Lingvay I
     Clinical and Safety Outcomes with GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes: A Real-World Study.
     J Clin Endocrinol Metab. 2022 Oct 21. pii: 6765301. doi: 10.1210.
     PubMed     Abstract available
     
     
     
329. STRAAT ME, Martinez-Tellez B, van Eyk HJ, Bizino MB, et al
     Differences in inflammatory pathways between Dutch South Asians versus Dutch Europids with type 2 diabetes.
     J Clin Endocrinol Metab. 2022 Oct 20. pii: 6763737. doi: 10.1210.
     PubMed     Abstract available
     
     
     
330. LEE B, Janzen C, Wu H, Vangala SS, et al
     Utility of In-vivo Magnetic Resonance Imaging is Predictive of Gestational Diabetes Mellitus during Early Pregnancy.
     J Clin Endocrinol Metab. 2022 Oct 17. pii: 6762303. doi: 10.1210.
     PubMed     Abstract available
     
     
     
331. MINSCHART C, Lammertyn A, Crombrugge PV, Moyson C, et al
     Low gestational weight gain in women with gestational diabetes is safe with better metabolic profile postpartum.
     J Clin Endocrinol Metab. 2022 Oct 14. pii: 6760796. doi: 10.1210.
     PubMed     Abstract available
     
     
     
332. O'ROURKE C, Ylescupidez A, Bahnson HT, Bender C, et al
     Risk Modeling to Reduce Monitoring of an Autoantibody-Positive Population to Prevent DKA at Type 1 Diabetes Diagnosis.
     J Clin Endocrinol Metab. 2022 Oct 13. pii: 6759855. doi: 10.1210.
     PubMed     Abstract available
     
     
     
333. VAN BAAL L, Reinold J, Benson S, Diehl A, et al
     Implications of a HbA1c based diabetes screening on prevalence and impact of dysglycemia in patients with COVID-19.
     J Clin Endocrinol Metab. 2022 Oct 12. pii: 6758527. doi: 10.1210.
     PubMed     Abstract available
     
     
     
334. MORI Y, Duru OK, Tuttle KR, Fukuma S, et al
     Sodium-Glucose Cotransporter 2 Inhibitors and New-onset Type 2 Diabetes in Adults with Prediabetes: systematic review and meta-analysis of randomized controlled trials.
     J Clin Endocrinol Metab. 2022 Oct 11. pii: 6755521. doi: 10.1210.
     PubMed     Abstract available
     
     
     
335. JIANG J, Wang H, Liu K, He S, et al
     Association of complement C3 with incident type 2 diabetes and the mediating role of BMI: A 10-year follow-up study.
     J Clin Endocrinol Metab. 2022 Oct 7. pii: 6751034. doi: 10.1210.
     PubMed     Abstract available
     
     
     
336. CIARDULLO S, Muraca E, Bianconi E, Cannistraci R, et al
     Diabetes mellitus is associated with higher serum neurofilament light chain levels in the general U.S. population.
     J Clin Endocrinol Metab. 2022 Oct 5. pii: 6748485. doi: 10.1210.
     PubMed     Abstract available
     
     
     
337. YANG G, Schooling CM
     Statins, type 2 diabetes and body mass index: a univariable and multivariable Mendelian randomization study.
     J Clin Endocrinol Metab. 2022 Oct 3. pii: 6746562. doi: 10.1210.
     PubMed     Abstract available
     
     
     
338. QIAN Y, Zhang Y, Fan X, Yan H, et al
     Full title: Nonalcoholic fatty liver disease and adverse pregnancy outcomes in women with normal prepregnant weight.
     J Clin Endocrinol Metab. 2022 Oct 1. pii: 6743167. doi: 10.1210.
     PubMed     Abstract available
     
     
     September 2022
339. YOSHII H, Mita T, Katakami N, Okada Y, et al
     The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control.
     J Clin Endocrinol Metab. 2022;107:e3990-e4003.
     PubMed     Abstract available
     
     
     
340. ZHANG D, Li Y, Lang X, Zhang Y, et al
     Associations of Serum Vitamin B6 Status and Catabolism With All-Cause Mortality in Patients With T2DM.
     J Clin Endocrinol Metab. 2022;107:2822-2832.
     PubMed     Abstract available
     
     
     
341. LUNATI ME, Fiorina P
     Antigen-based Immunotherapy Improves Glycemic Metrics and beta-Cell Function.
     J Clin Endocrinol Metab. 2022;107:e4250-e4251.
     PubMed    
     
     
     
342. BORGHI C, Guaraldi F
     Uric Acid, Genetic Scores and Renal Disease: Merge to Separate?
     J Clin Endocrinol Metab. 2022;107:e4234-e4235.
     PubMed    
     
     
     
343. DE CASTRO M, Silva Martins C
     Integrating Molecular and Metabolomic Markers in T1D Enables Precocious Interventions: Are We Getting There?
     J Clin Endocrinol Metab. 2022;107:e4240-e4241.
     PubMed    
     
     
     
344. KOUFAKIS T, Vas P, Maltese G, Kotsa K, et al
     Antiatherosclerotic Effects of Sodium-Glucose Cotransporter 2 Inhibitors: An Underrecognized Piece of the Big Puzzle?
     J Clin Endocrinol Metab. 2022;107:e4244-e4245.
     PubMed    
     
     
     
345. LAURSEN JC, Mizrak HI, Kufaishi H, Hecquet SK, et al
     Lower blood oxygen saturation is associated with microvascular complications in individuals with type 1 diabetes.
     J Clin Endocrinol Metab. 2022 Sep 22. pii: 6711572. doi: 10.1210.
     PubMed     Abstract available
     
     
     
346. NA Y, Kim SW, Park IB, Choi SJ, et al
     Association between DPP4 inhibitor use and the incidence of cirrhosis, ESRD, and some cancers in patients with diabetes.
     J Clin Endocrinol Metab. 2022 Sep 15. pii: 6701630. doi: 10.1210.
     PubMed     Abstract available
     
     
     
347. MINGRONE G, Castagneto-Gissey L, Bornstein SR
     New Horizons: Emerging anti-diabetic medications.
     J Clin Endocrinol Metab. 2022 Sep 15. pii: 6694192. doi: 10.1210.
     PubMed     Abstract available
     
     
     
348. NESTEL P, Loh WJ, Ward NC, Watts GF, et al
     New Horizons: Revival of Lipoprotein (a) as a risk factor for cardiovascular disease.
     J Clin Endocrinol Metab. 2022 Sep 15. pii: 6701631. doi: 10.1210.
     PubMed     Abstract available
     
     
     
349. 
     Correction to: "Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes".
     J Clin Endocrinol Metab. 2022 Sep 14. pii: 6698734. doi: 10.1210.
     PubMed    
     
     
     
350. 
     Correction to "A Simple Test to Identify the Risk of NASH and Cirrhosis in People With Obesity or Diabetes: The Time to Screen Is Now".
     J Clin Endocrinol Metab. 2022 Sep 9. pii: 6694959. doi: 10.1210.
     PubMed    
     
     
     
351. YANG S, Liu C, Ye Z, Zhou C, et al
     Variety and quantity of dietary insoluble fibers intake from different sources and risk of new-onset diabetes.
     J Clin Endocrinol Metab. 2022 Sep 8. pii: 6694193. doi: 10.1210.
     PubMed     Abstract available
     
     
     
352. PEREA V, Simo-Servat A, Quiros C, Alonso-Carril N, et al
     Role of Excessive Weight Gain During Gestation in the Risk of ADHD in Offspring of Women With Gestational Diabetes.
     J Clin Endocrinol Metab. 2022 Sep 8. pii: 6693733. doi: 10.1210.
     PubMed     Abstract available
     
     
     
353. GRACE SL, Bowden J, Walkey HC, Kaur A, et al
     Islet autoantibody level distribution in type 1 diabetes and their association with genetic and clinical characteristics.
     J Clin Endocrinol Metab. 2022 Sep 8. pii: 6693901. doi: 10.1210.
     PubMed     Abstract available
     
     
     
354. LI Y, Gao R, Zhao B, Zhang Y, et al
     Low serum bicarbonate levels increased the risk of all-cause, cardiovascular and cancer Mortality in type 2 diabetes.
     J Clin Endocrinol Metab. 2022 Sep 6. pii: 6692819. doi: 10.1210.
     PubMed     Abstract available
     
     
     
355. BOGDANET D, Luque-Fernandez MA, Toth-Castillo M, Desoye G, et al
     The role of early pregnancy maternal pGCD59 levels in predicting neonatal hypoglycaemia- sub-analysis of the DALI study.
     J Clin Endocrinol Metab. 2022 Sep 2. pii: 6687612. doi: 10.1210.
     PubMed     Abstract available
     
     
     August 2022
356. ADEMOLU AB
     Branched Chain Amino Acids and Gestational Diabetes Mellitus.
     J Clin Endocrinol Metab. 2022 Aug 22. pii: 6673262. doi: 10.1210.
     PubMed    
     
     
     
357. ROSSI A, Venema A, Haarsma P, Feldbrugge L, et al
     A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets.
     J Clin Endocrinol Metab. 2022;107:e3612-e3623.
     PubMed     Abstract available
     
     
     
358. GRAY SM, Hoselton AL, Krishna R, Slentz CA, et al
     GLP-1 Receptor Blockade Reduces Stimulated Insulin Secretion in Fasted Subjects With Low Circulating GLP-1.
     J Clin Endocrinol Metab. 2022;107:2500-2510.
     PubMed     Abstract available
     
     
     
359. DORSEY-TREVINO EG, Kaur V, Mercader JM, Florez JC, et al
     Association of GLP1R Polymorphisms With the Incretin Response.
     J Clin Endocrinol Metab. 2022;107:2580-2588.
     PubMed     Abstract available
     
     
     
360. CHAN KE, Koh TJL, Tang ASP, Quek J, et al
     Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals.
     J Clin Endocrinol Metab. 2022;107:2691-2700.
     PubMed     Abstract available
     
     
     
361. LIU J, Wang L, Qian Y, Shen Q, et al
     Metabolic and genetic markers improve prediction of incident type 2 diabetes: A nested case-control study in Chinese.
     J Clin Endocrinol Metab. 2022 Aug 17. pii: 6670765. doi: 10.1210.
     PubMed     Abstract available
     
     
     
362. DONG Y, Chen Z, Gong Y, Han Y, et al
     The Risks of Cardiovascular Disease Following Weight Change in Adults with Diabetes: A Cohort Study and Meta-analysis (jc.2022-01089).
     J Clin Endocrinol Metab. 2022 Aug 16. pii: 6666536. doi: 10.1210.
     PubMed     Abstract available
     
     
     
363. DONG Y, Chen Z, Gong Y, Han Y, et al
     The Risks of Cardiovascular Disease Following Weight Change in Adults with Diabetes: A Cohort Study and Meta-analysis.
     J Clin Endocrinol Metab. 2022 Aug 15. pii: 6666536. doi: 10.1210.
     PubMed     Abstract available
     
     
     
364. ZAHARIA OP, Schon M, Loffler L, Strassburger K, et al
     Metabolic factors predict changes in endothelial function during the early course of type 1 and type 2 diabetes.
     J Clin Endocrinol Metab. 2022 Aug 15. pii: 6666026. doi: 10.1210.
     PubMed     Abstract available
     
     
     
365. KAUSHAL T, Tinsley LJ, Volkening LK, Turcotte C, et al
     Improved CGM Glucometrics and More Visits in Pediatric Type 1 Diabetes using Telemedicine During 1 Year of COVID-19.
     J Clin Endocrinol Metab. 2022 Aug 11. pii: 6660713. doi: 10.1210.
     PubMed     Abstract available
     
     
     
366. HIERSCH L, Shah BR, Berger H, Geary M, et al
     Screening accuracy of the 50g-glucose challenge test in twin compared with singleton pregnancies.
     J Clin Endocrinol Metab. 2022 Aug 5. pii: 6656583. doi: 10.1210.
     PubMed     Abstract available
     
     
     
367. 
     Correction to: Deterioration of Glycemic Control in Youth-Onset Type 2 Diabetes: What Are the Early and Late Predictors?
     J Clin Endocrinol Metab. 2022 Aug 4. pii: 6655793. doi: 10.1210.
     PubMed    
     
     
     
368. DHANASEKARAN M, Mohan S, Erickson D, Shah P, et al
     Diabetic Ketoacidosis in Pregnancy: Clinical Risk factors, Presentation, and Outcomes.
     J Clin Endocrinol Metab. 2022 Aug 2. pii: 6653511. doi: 10.1210.
     PubMed     Abstract available
     
     
     
369. KIVELA J, Meinila J, Uusitupa M, Tuomilehto J, et al
     Longitudinal branched-chain amino acids, lifestyle intervention and type 2 diabetes in Finnish Diabetes Prevention Study.
     J Clin Endocrinol Metab. 2022 Aug 2. pii: 6653510. doi: 10.1210.
     PubMed     Abstract available
     
     
     
370. WANG CY, Huang KC, Lu CW, Chu CH, et al
     A randomized controlled trial of R-form verapamil added to ongoing metformin therapy in patients with type 2 diabetes.
     J Clin Endocrinol Metab. 2022 Aug 2. pii: 6653488. doi: 10.1210.
     PubMed     Abstract available
     
     
     
371. BALLESTEROS M, Gil-Lluis P, Ejarque M, Diaz-Perdigones C, et al
     DNA methylation in gestational diabetes and its predictive value for postpartum glucose disturbances.
     J Clin Endocrinol Metab. 2022 Aug 2. pii: 6653115. doi: 10.1210.
     PubMed     Abstract available
     
     
     
372. SUN L, Duan T, Zhao Q, Xu L, et al
     Crescent, an independent risk factor for the progression of type 2 diabetic kidney disease.
     J Clin Endocrinol Metab. 2022 Aug 1. pii: 6653067. doi: 10.1210.
     PubMed     Abstract available
     
     
     July 2022
373. TANABE H, Hirai H, Saito H, Tanaka K, et al
     Detecting Sarcopenia Risk by Diabetes Clustering: A Japanese Prospective Cohort Study.
     J Clin Endocrinol Metab. 2022 Jul 31. pii: 6652583. doi: 10.1210.
     PubMed     Abstract available
     
     
     
374. POWE CE, Locascio JJ, Florez JC, Catalano PM, et al
     Response to Letter to the Editor From Gobl and Tura: "Oral Glucose Tolerance Test-based Measures of Insulin Secretory Response in Pregnancy".
     J Clin Endocrinol Metab. 2022 Jul 29. pii: 6651612. doi: 10.1210.
     PubMed    
     
     
     
375. JACOBSEN LM, Bundy BN, Ismail HM, Clements M, et al
     Index60 Is Superior to HbA1c for Identifying Individuals at High Risk for Type 1 Diabetes.
     J Clin Endocrinol Metab. 2022 Jul 26. pii: 6650147. doi: 10.1210.
     PubMed     Abstract available
     
     
     
376. VALENCIA-MARTINEZ A, Schaefer-Graf U, Amusquivar E, Herrera E, et al
     Relationship of ANGPTL6 with neonatal glucose homeostasis and fat mass is disrupted in gestational diabetic pregnancies.
     J Clin Endocrinol Metab. 2022 Jul 25. pii: 6649565. doi: 10.1210.
     PubMed     Abstract available
     
     
     
377. TATULASHVILI S, Julla JB, Sritharan N, Rezgani I, et al
     Ambulatory glucose profile according to different phases of the menstrual cycle in women living with type 1 diabetes.
     J Clin Endocrinol Metab. 2022 Jul 23. pii: 6648857. doi: 10.1210.
     PubMed     Abstract available
     
     
     
378. SU L, He J, Liu Z, Wu S, et al
     Dietary Total Vitamin A, beta-Carotene and Retinol Intake and the Risk of Diabetes in Chinese Adults with Plant-Based Diets.
     J Clin Endocrinol Metab. 2022 Jul 22. pii: 6648797. doi: 10.1210.
     PubMed     Abstract available
     
     
     
379. JIMENEZ-SANCHEZ C, Mezza T, Sinturel F, Li L, et al
     Circulating 1,5-anhydroglucitol as a biomarker of ss-cell mass independent of a diabetes phenotype in human subjects.
     J Clin Endocrinol Metab. 2022 Jul 22. pii: 6648530. doi: 10.1210.
     PubMed     Abstract available
     
     
     
380. WANG X, Guo B, Yang X, Li J, et al
     Role of liver enzymes in the relationship between particulate matter exposure and diabetes risk: a longitudinal cohort study.
     J Clin Endocrinol Metab. 2022 Jul 21. pii: 6647990. doi: 10.1210.
     PubMed     Abstract available
     
     
     
381. MITA T, Katakami N, Takahara M, Kawashima M, et al
     Changes in Treatment Satisfaction Over 3 Years in Patients With Type 2 Diabetes After Initiating Second-line Treatment.
     J Clin Endocrinol Metab. 2022 Jul 20. pii: 6647028. doi: 10.1210.
     PubMed     Abstract available
     
     
     
382. ZENZ S, Regittnig W, Boulgaropoulos B, Augustin T, et al
     Effect of Liraglutide Treatment on Whole Body Glucose Fluxes in C-peptide Positive Type 1 Diabetes During Hypoglycaemia.
     J Clin Endocrinol Metab. 2022 Jul 14. pii: 6644078. doi: 10.1210.
     PubMed     Abstract available
     
     
     
383. KORYTKOWSKI MT, Muniyappa R, Antinori-Lent K, Donihi AC, et al
     Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline.
     J Clin Endocrinol Metab. 2022;107:2101-2128.
     PubMed     Abstract available
     
     
     
384. SEISA MO, Saadi S, Nayfeh T, Muthusamy K, et al
     A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline for the Management of Hyperglycemia in Adults Hospitalized for Noncritical Illness or Undergoing Elective Surgical Procedures.
     J Clin Endocrinol Metab. 2022;107:2139-2147.
     PubMed     Abstract available
     
     
     
385. LUO Y, Wang J, Sun L, Gu W, et al
     Isocaloric-restricted Mediterranean Diet and Chinese Diets High or Low in Plants in Adults With Prediabetes.
     J Clin Endocrinol Metab. 2022;107:2216-2227.
     PubMed     Abstract available
     
     
     
386. CLEMMENSEN KKB, Koster A, Nielen YTH, Dagnelie PC, et al
     Role of Weekday Variation on Glucose, Insulin, and Triglyceride: A Cross-Sectional Analysis From the Maastricht Study.
     J Clin Endocrinol Metab. 2022;107:e3145-e3151.
     PubMed     Abstract available
     
     
     
387. KUMAR N, D'Alessio DA
     Slow and Steady Wins the Race: 25 Years Developing the GLP-1 Receptor as an Effective Target for Weight Loss.
     J Clin Endocrinol Metab. 2022;107:2148-2153.
     PubMed     Abstract available
     
     
     
388. REMCHAK ME, Heiston EM, Ballantyne A, Dotson BL, et al
     Insulin Sensitivity and Metabolic Flexibility Parallel Plasma TCA Levels in Early Chronotype With Metabolic Syndrome.
     J Clin Endocrinol Metab. 2022;107:e3487-e3496.
     PubMed     Abstract available
     
     
     
389. ESPOSITO D, Olsson DS, Franzen S, Miftaraj M, et al
     Impact of Diabetes on Morbidity and Mortality in Patients with Acromegaly.
     J Clin Endocrinol Metab. 2022 Jul 2. pii: 6627438. doi: 10.1210.
     PubMed     Abstract available
     
     
     
390. DICHTEL LE, Corey KE, Haines MS, Chicote ML, et al
     The GH/IGF-1 axis is associated with intrahepatic lipid content and hepatocellular damage in overweight/obesity.
     J Clin Endocrinol Metab. 2022 Jul 2. pii: 6627589. doi: 10.1210.
     PubMed     Abstract available
     
     
     
391. HSIAO FC, Yen KC, Chao TF, Chen SW, et al
     New-onset atrial fibrillation in patients with type 2 diabetes treated with novel glucose lowering therapies.
     J Clin Endocrinol Metab. 2022 Jul 1. pii: 6625758. doi: 10.1210.
     PubMed     Abstract available
     
     
     
392. WANG X, Ma H, Gupta S, Heianza Y, et al
     The joint secular trends of sleep quality and diabetes among the US adults, 2005-2018.
     J Clin Endocrinol Metab. 2022 Jul 1. pii: 6625709. doi: 10.1210.
     PubMed     Abstract available
     
     
     June 2022
393. TOMKINS M, Lawless S, Martin-Grace J, Sherlock M, et al
     Diagnosis and Management of Central Diabetes Insipidus in Adults.
     J Clin Endocrinol Metab. 2022 Jun 30. pii: 6623615. doi: 10.1210.
     PubMed     Abstract available
     
     
     
394. DO NC, Vestgaard M, Asbjornsdottir B, Andersen LLT, et al
     Home blood pressure for the prediction of preeclampsia in women with pre-existing diabetes.
     J Clin Endocrinol Metab. 2022 Jun 29. pii: 6619549. doi: 10.1210.
     PubMed     Abstract available
     
     
     
395. SUN Y, Hong L, Huang Z, Wang L, et al
     Fibrosis Risk in Nonalcoholic Fatty Liver Disease is Related to Chronic Kidney Disease in Aged Type 2 Diabetes Patients.
     J Clin Endocrinol Metab. 2022 Jun 29. pii: 6619454. doi: 10.1210.
     PubMed     Abstract available
     
     
     
396. CHEUNG YM, Hughes M, Harrod J, Files J, et al
     The effects of diabetes and glycemic control on cancer outcomes in individuals with metastatic breast cancer.
     J Clin Endocrinol Metab. 2022 Jun 29. pii: 6619488. doi: 10.1210.
     PubMed     Abstract available
     
     
     
397. FLACHS MADSEN LR, Gerdoe-Kristensen S, Lauenborg J, Damm P, et al
     Long-term follow-up on morbidity among women with a history of gestational diabetes mellitus: a systematic review.
     J Clin Endocrinol Metab. 2022 Jun 28. pii: 6619270. doi: 10.1210.
     PubMed     Abstract available
     
     
     
398. ZACCARDI F, Khunti K
     Risk of diabetes following COVID-19: Translating evidence into clinical and public health actions.
     J Clin Endocrinol Metab. 2022 Jun 24. pii: 6617556. doi: 10.1210.
     PubMed    
     
     
     
399. SOH JGS, Mukhopadhyay A, Mohankumar B, Quek SC, et al
     Predicting and validating 30-day hospital readmission in adults with diabetes whose index admission is diabetes-related.
     J Clin Endocrinol Metab. 2022 Jun 23. pii: 6615329. doi: 10.1210.
     PubMed     Abstract available
     
     
     
400. WANG CH, Lu WL, Chiang SL, Tsai TH, et al
     T cells mediate kidney tubular injury via impaired PDHA1 and Autophagy in type 1 diabetes.
     J Clin Endocrinol Metab. 2022 Jun 22. pii: 6613175. doi: 10.1210.
     PubMed     Abstract available
     
     
     
401. CHANG VILLACRESES MM, Karnchanasorn R, Panjawatanan P, Ou HY, et al
     Letter to the Editor From Chang Villacreses et al: "Effects of Vitamin D Supplementation on Insulin Sensitivity and Secretion in Prediabetes".
     J Clin Endocrinol Metab. 2022;107:e3086-e3087.
     PubMed    
     
     
     
402. RASOULI N, Pittas AG
     Response to Letter to the Editor From Chang Villacreses et al: "Effects of Vitamin D Supplementation on Insulin Sensitivity and Secretion in Prediabetes".
     J Clin Endocrinol Metab. 2022;107:e3095-e3096.
     PubMed    
     
     
     
403. HUMMEL J, Kullmann S, Heni M
     Spotlight on the Human Brain: Central Actions of SGLT2 Inhibitors?
     J Clin Endocrinol Metab. 2022;107:e3080-e3081.
     PubMed    
     
     
     
404. BALASUBRAMANIAN P, Wanner C, Ferreira JP, Ofstad AP, et al
     Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition?
     J Clin Endocrinol Metab. 2022;107:e3003-e3007.
     PubMed     Abstract available
     
     
     
405. HOU T, Li M, Lin H, Zhao Z, et al
     The causal effect of systolic blood pressure lowering on vascular outcomes in diabetes: a Mendelian randomization study.
     J Clin Endocrinol Metab. 2022 Jun 15. pii: 6608757. doi: 10.1210.
     PubMed     Abstract available
     
     
     
406. LECAMWASAM A, Ekinci EI
     Novel associations of empagliflozin on the gut microbiome and metabolome in type 2 diabetes.
     J Clin Endocrinol Metab. 2022 Jun 8. pii: 6604095. doi: 10.1210.
     PubMed    
     
     
     
407. NOWAK C, Lind M, Sumnik Z, Pelikanova T, et al
     Intralymphatic GAD-alum (Diamyd(R)) improves glycaemic control in Type 1 diabetes with HLA DR3-DQ2.
     J Clin Endocrinol Metab. 2022 Jun 6. pii: 6602344. doi: 10.1210.
     PubMed     Abstract available
     
     
     
408. ZHANG Z, Piro AL, Allalou A, Alexeeff SE, et al
     Prolactin and maternal metabolism in women with a recent GDM pregnancy and links to future T2D: the SWIFT study.
     J Clin Endocrinol Metab. 2022 Jun 6. pii: 6603090. doi: 10.1210.
     PubMed     Abstract available
     
     
     
409. SULAJ A, Kopf S, von Rauchhaupt E, Kliemank E, et al
     Six-Month Periodic Fasting in Patients With Type 2 Diabetes and Diabetic Nephropathy: A Proof-of-Concept Study.
     J Clin Endocrinol Metab. 2022 Jun 5. pii: 6576281. doi: 10.1210.
     PubMed     Abstract available
     
     
     
410. 
     Correction to: Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline.
     J Clin Endocrinol Metab. 2022 Jun 1. pii: 6596832. doi: 10.1210.
     PubMed    
     
     
     
411. DENIMAL D, Benanaya S, Monier S, Simoneau I, et al
     Normal HDL cholesterol efflux and anti-inflammatory capacities in type 2 diabetes despite lipidomic abnormalities.
     J Clin Endocrinol Metab. 2022 Jun 1. pii: 6596673. doi: 10.1210.
     PubMed     Abstract available
     
     
     
412. BETTINI S, Milan G, Favaretto F, Fabris R, et al
     Metabolic slowing vanished 5 years after sleeve gastrectomy in patients with obesity and prediabetes/diabetes.
     J Clin Endocrinol Metab. 2022 Jun 1. pii: 6596593. doi: 10.1210.
     PubMed     Abstract available
     
     
     May 2022
413. WU P, Wang Y, Ye Y, Yang X, et al
     Serum fetuin-A and risk of gestational diabetes mellitus: an observational study and Mendelian randomization analysis.
     J Clin Endocrinol Metab. 2022 May 30. pii: 6595431. doi: 10.1210.
     PubMed     Abstract available
     
     
     
414. PAL R, Bhadada SK
     Glycemic control in youth-onset type 2 diabetes: Predicting the tomorrow based on lessons learnt from TODAY.
     J Clin Endocrinol Metab. 2022 May 30. pii: 6594952. doi: 10.1210.
     PubMed    
     
     
     
415. KEHLENBRINK S, Ansbro E, Besancon S, Hassan S, et al
     Strengthening Diabetes Care In Humanitarian Crises In Low- And Middle-Income Settings.
     J Clin Endocrinol Metab. 2022 May 27. pii: 6594228. doi: 10.1210.
     PubMed     Abstract available
     
     
     
416. KIM H, Bae S, Yoon HY, Yee J, et al
     Association of SLC47A1 gene variant with responses to metformin monotherapy in drug-naive patients with type 2 diabetes: A systematic review and meta-analysis.
     J Clin Endocrinol Metab. 2022 May 27. pii: 6594177. doi: 10.1210.
     PubMed     Abstract available
     
     
     
417. JALLEH RJ, Wu T, Jones KL, Rayner CK, et al
     Relationships of glucose, GLP-1 and insulin secretion with gastric emptying after a 75g glucose load in type 2 diabetes.
     J Clin Endocrinol Metab. 2022 May 24. pii: 6591320. doi: 10.1210.
     PubMed     Abstract available
     
     
     
418. LETO G, Tartaglione L, Rotondi S, Pasquali M, et al
     Diastolic Pressure And Acr Are Modifiable Risk Factors Of Arterial Stiffness In T2DM Without Cardiovascular Disease.
     J Clin Endocrinol Metab. 2022 May 20. pii: 6590071. doi: 10.1210.
     PubMed     Abstract available
     
     
     
419. WONG KK, Cheng F, Mao D, Lim CKP, et al
     Vitamin D levels during pregnancy are associated with offspring telomere length: a longitudinal mother-child study.
     J Clin Endocrinol Metab. 2022 May 19. pii: 6588722. doi: 10.1210.
     PubMed     Abstract available
     
     
     
420. MAIO A, Maiorino MI, Longo M, Scappaticcio L, et al
     Change in circulating levels of endothelial progenitor cells and sexual function in women with type 1 diabetes.
     J Clin Endocrinol Metab. 2022 May 18. pii: 6588130. doi: 10.1210.
     PubMed     Abstract available
     
     
     
421. PATEL KA, Burman S, Laver TW, Hattersley AT, et al
     PLIN1 Haploinsufficiency Causes a Favorable Metabolic Profile.
     J Clin Endocrinol Metab. 2022;107:e2318-e2323.
     PubMed     Abstract available
     
     
     
422. HOYBYE C, Tauber M
     Approach to the Patient With Prader-Willi Syndrome.
     J Clin Endocrinol Metab. 2022;107:1698-1705.
     PubMed     Abstract available
     
     
     
423. CHRIST-CRAIN M, Refardt J, Winzeler B
     Approach to the Patient: "Utility of the Copeptin Assay".
     J Clin Endocrinol Metab. 2022;107:1727-1738.
     PubMed     Abstract available
     
     
     
424. VUKAJLOVIC T, Sailer CO, Asmar A, Jensen BL, et al
     Effect of a 3-Week Treatment with GLP-1 Receptor Agonists on Vasoactive Hormones in Euvolemic Participants.
     J Clin Endocrinol Metab. 2022;107:e2581-e2589.
     PubMed     Abstract available
     
     
     
425. SUN Y, Yu Y, Zhang H, Wang B, et al
     Joint exposure to positive affect, life satisfaction, depressive symptoms, and neuroticism and incident type 2 diabetes.
     J Clin Endocrinol Metab. 2022 May 12. pii: 6584952. doi: 10.1210.
     PubMed     Abstract available
     
     
     
426. KOUFAKIS T, Dhatariya KK, Kotsa K
     Potential role of ultra-fast acting insulin analogues in the treatment of diabetic ketoacidosis.
     J Clin Endocrinol Metab. 2022 May 11. pii: 6584505. doi: 10.1210.
     PubMed    
     
     
     
427. BAIDAL DA, Warnock M, Xu P, Geyer S, et al
     Oral Glucose Tolerance Test Measures of First-Phase Insulin Response and their Predictive Ability for Type 1 Diabetes.
     J Clin Endocrinol Metab. 2022 May 7. pii: 6582280. doi: 10.1210.
     PubMed     Abstract available
     
     
     
428. NIMRI R, Marianna R, Yackobovitch-Gavan M, Brener A, et al
     Symptoms and Glycemic Control in Young People with Type 1 Diabetes following SARS-CoV-2 Infection: an Observational Study.
     J Clin Endocrinol Metab. 2022 May 7. pii: 6582248. doi: 10.1210.
     PubMed     Abstract available
     
     
     
429. LAT J, Caprio S
     Understanding the Pathophysiology of Youth-Onset Type 2 Diabetes (T2D): Importance of alpha-cell function.
     J Clin Endocrinol Metab. 2022 May 5. pii: 6581067. doi: 10.1210.
     PubMed    
     
     
     April 2022
430. ZEITLER P, El Ghormli L, Arslanian S, Caprio S, et al
     Deterioration of glycemic control in youth-onset type 2 diabetes: what are the early and late predictors?
     J Clin Endocrinol Metab. 2022 Apr 29. pii: 6576101. doi: 10.1210.
     PubMed     Abstract available
     
     
     
431. WEBB-ROBERTSON BM, Nakayasu ES, Frohnert BI, Bramer LM, et al
     Integration of Infant Metabolite, Genetic and Islet Autoimmunity Signatures to Predict Type 1 Diabetes by 6 Years of Age.
     J Clin Endocrinol Metab. 2022 Apr 25. pii: 6573923. doi: 10.1210.
     PubMed     Abstract available
     
     
     
432. SUN Z, Hu Y, Yu C, Guo Y, et al
     Low-risk lifestyle and health factors and risk of mortality and vascular complications in Chinese patients with diabetes.
     J Clin Endocrinol Metab. 2022 Apr 23. pii: 6573307. doi: 10.1210.
     PubMed     Abstract available
     
     
     
433. JIA X, Toda K, He L, Miao D, et al
     Expression-based Genome-Wide Association Study Links OPN and IL1-RA with Newly Diagnosed Type 1 Diabetes in Children.
     J Clin Endocrinol Metab. 2022 Apr 23. pii: 6572806. doi: 10.1210.
     PubMed     Abstract available
     
     
     
434. SUZUKI Y, Kaneko H, Okada A, Matsuoka S, et al
     Prediabetes in Young Adults and Its Association with Cardiovascular Health Metrics in the Progression to Diabetes.
     J Clin Endocrinol Metab. 2022 Apr 21. pii: 6572042. doi: 10.1210.
     PubMed     Abstract available
     
     
     
435. CUKIERMAN-YAFFE T, Gerstein HC, Basile J, Bethel MA, et al
     Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
     J Clin Endocrinol Metab. 2022 Apr 21. pii: 6569991. doi: 10.1210.
     PubMed     Abstract available
     
     
     
436. DHALIWAL R, Pereira RI, Diaz-Thomas AM, Powe CE, et al
     Eradicating Racism: An Endocrine Society Policy Perspective.
     J Clin Endocrinol Metab. 2022;107:1205-1215.
     PubMed     Abstract available
     
     
     
437. HAN E, Han KD, Lee BW, Kang ES, et al
     Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-based Cohort Study.
     J Clin Endocrinol Metab. 2022;107:e1976-e1986.
     PubMed     Abstract available
     
     
     
438. LINGVAY I, Bauer R, Baker-Knight J, Lawson J, et al
     An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression.
     J Clin Endocrinol Metab. 2022;107:1461-1469.
     PubMed     Abstract available
     
     
     
439. SOVIO U, Clayton GL, Cook E, Gaccioli F, et al
     Metabolomic identification of a novel, externally validated predictive test for gestational diabetes mellitus.
     J Clin Endocrinol Metab. 2022 Apr 18. pii: 6570001. doi: 10.1210.
     PubMed     Abstract available
     
     
     
440. WAN Z, Shan Z, Geng T, Lu Q, et al
     Associations of Moderate Low-Carbohydrate Diets with Mortality among Patients with Type 2 Diabetes: A Prospective Cohort Study.
     J Clin Endocrinol Metab. 2022 Apr 16. pii: 6569394. doi: 10.1210.
     PubMed     Abstract available
     
     
     
441. CIARDULLO S, Rea F, Savare L, Morabito G, et al
     Prolonged use of proton pump inhibitors and risk of type 2 diabetes: results from a large population-based nested case-control study.
     J Clin Endocrinol Metab. 2022 Apr 16. pii: 6569190. doi: 10.1210.
     PubMed     Abstract available
     
     
     
442. GRESPAN E, Guolo A, Muscelli E, Ferrannini E, et al
     Loss of the incretin effect in type 2 diabetes: a systematic review and meta-analysis.
     J Clin Endocrinol Metab. 2022 Apr 9. pii: 6565992. doi: 10.1210.
     PubMed     Abstract available
     
     
     
443. DENG X, Zhang C, Wang P, Wei W, et al
     Cardiovascular benefits of empagliflozin are associated with gut microbiota and plasma metabolites in type 2 diabetes.
     J Clin Endocrinol Metab. 2022 Apr 9. pii: 6565990. doi: 10.1210.
     PubMed     Abstract available
     
     
     
444. KAZE AD, Yuyun MF, Erqou S, Fonarow GC, et al
     Severe Hypoglycemia and Incidence of QT Interval Prolongation Among Adults with Type 2 Diabetes.
     J Clin Endocrinol Metab. 2022 Apr 9. pii: 6565648. doi: 10.1210.
     PubMed     Abstract available
     
     
     
445. SEAH JYH, Hong Y, Cichonska A, Sabanayagam C, et al
     Circulating metabolic biomarkers are consistently associated with type 2 diabetes risk in Asian and European populations.
     J Clin Endocrinol Metab. 2022 Apr 7. pii: 6564834. doi: 10.1210.
     PubMed     Abstract available
     
     
     
446. LAVIK AR, Ebekozien O, Noor N, Alonso GT, et al
     Trends in type 1 diabetic ketoacidosis during COVID-19 surges at seven US centers: highest burden on non-Hispanic Blacks.
     J Clin Endocrinol Metab. 2022 Apr 5. pii: 6555827. doi: 10.1210.
     PubMed     Abstract available
     
     
     
447. SCHMITT JA, Ashraf AP, Becker DJ, Sen B, et al
     Changes in Type 2 diabetes trends in Children and Adolescents during the COVID-19 Pandemic.
     J Clin Endocrinol Metab. 2022 Apr 4. pii: 6563173. doi: 10.1210.
     PubMed     Abstract available
     
     
     
448. GURUNG RL, M Y, Liu JJ, Dorajoo R, et al
     Genetic risk score for plasma uric acid levels is associated with early rapid kidney function decline in type 2 diabetes.
     J Clin Endocrinol Metab. 2022 Apr 1. pii: 6562385. doi: 10.1210.
     PubMed     Abstract available
     
     
     
449. SAARI T, Koffert J, Honka H, Kauhanen S, et al
     Obesity associated blunted subcutaneous adipose tissue blood flow after meal is improved after bariatric surgery.
     J Clin Endocrinol Metab. 2022 Apr 1. pii: 6562287. doi: 10.1210.
     PubMed     Abstract available
     
     
     March 2022
450. SCHEUER SH, Kosjerina V, Lindekilde N, Pouwer F, et al
     Severe mental illness and the risk of diabetes complications. A nationwide register-based cohort study.
     J Clin Endocrinol Metab. 2022 Mar 31. pii: 6561847. doi: 10.1210.
     PubMed     Abstract available
     
     
     
451. FURSE S, Koulman A, Ozanne SE, Poston L, et al
     Altered lipid metabolism in obese women with gestational diabetes and associations with offspring adiposity.
     J Clin Endocrinol Metab. 2022 Mar 31. pii: 6561850. doi: 10.1210.
     PubMed     Abstract available
     
     
     
452. CUSI K
     A Simple Test to Identify the Risk of NASH and Cirrhosis in People with Obesity or Diabetes: The Time to Screen is Now.
     J Clin Endocrinol Metab. 2022 Mar 25. pii: 6554286. doi: 10.1210.
     PubMed    
     
     
     
453. HE P, Liu C, Qin X
     Response to Letter to the Editor From Pattan et al.: "U-shaped Association Between Dietary Zinc Intake and New-onset Diabetes: A Nationwide Cohort Study in China".
     J Clin Endocrinol Metab. 2022 Mar 24. pii: 6553918. doi: 10.1210.
     PubMed    
     
     
     
454. PATTAN V, Chang Villacreses MM, Karnchanasorn R, Chiu KC, et al
     Letter to the Editor From Pattan et al.: "U-shaped Association Between Dietary Zinc Intake and New-onset Diabetes: A Nationwide Cohort Study in China".
     J Clin Endocrinol Metab. 2022 Mar 24. pii: 6553916. doi: 10.1210.
     PubMed    
     
     
     
455. GUO K, Savelieff MG, Rumora AE, Alakwaa FM, et al
     Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status.
     J Clin Endocrinol Metab. 2022;107:1091-1109.
     PubMed     Abstract available
     
     
     
456. KOPRULU M, Zhao Y, Wheeler E, Dong L, et al
     Identification of Rare Loss-of-Function Genetic Variation Regulating Body Fat Distribution.
     J Clin Endocrinol Metab. 2022;107:1065-1077.
     PubMed     Abstract available
     
     
     
457. SCULLY KJ, Sherwood JS, Martin K, Ruazol M, et al
     Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.
     J Clin Endocrinol Metab. 2022;107:e1444-e1454.
     PubMed     Abstract available
     
     
     
458. JAROSINSKI MA, Chen YS, Varas N, Dhayalan B, et al
     New Horizons: Next-Generation Insulin Analogues: Structural Principles and Clinical Goals.
     J Clin Endocrinol Metab. 2022;107:909-928.
     PubMed     Abstract available
     
     
     
459. SHI FH, Li H, Shen L, Xu L, et al
     Beneficial Effect of Sodium-Glucose Co-transporter 2 Inhibitors on Left Ventricular Function.
     J Clin Endocrinol Metab. 2022;107:1191-1203.
     PubMed     Abstract available
     
     
     
460. RAMEZANI TEHRANI F, Behboudi-Gandevani S, Farzadfar F, Hosseinpanah F, et al
     A cluster randomized noninferiority field trial of gestational diabetes mellitus screening.
     J Clin Endocrinol Metab. 2022 Mar 23. pii: 6553153. doi: 10.1210.
     PubMed     Abstract available
     
     
     
461. SOHOLM JC, Do NC, Vestgaard M, Asbjornsdottir B, et al
     Falling insulin requirement in pregnant women with diabetes delivering preterm - prevalence, predictors and consequences.
     J Clin Endocrinol Metab. 2022 Mar 18. pii: 6550636. doi: 10.1210.
     PubMed     Abstract available
     
     
     
462. AU PCM, Tan KCB, Cheung BMY, Wong ICK, et al
     Association between SGLT2 Inhibitors vs DPP4 Inhibitors and Renal Outcomes Among Patients with Type 2 Diabetes.
     J Clin Endocrinol Metab. 2022 Mar 18. pii: 6550649. doi: 10.1210.
     PubMed     Abstract available
     
     
     
463. LABADZHYAN A, Wentzel K, Hamid O, Chow K, et al
     Endocrine autoantibodies determine immune checkpoint inhibitor-induced endocrinopathy: a prospective study.
     J Clin Endocrinol Metab. 2022 Mar 18. pii: 6550635. doi: 10.1210.
     PubMed     Abstract available
     
     
     
464. BAO X, Xu B, Yin S, Pan J, et al
     Proteomic Profiles of Body Mass Index and Waist-to-Hip Ratio and their Role in Incidence of Diabetes.
     J Clin Endocrinol Metab. 2022 Mar 16. pii: 6549707. doi: 10.1210.
     PubMed     Abstract available
     
     
     
465. JIANG W, Song Q, Zhang J, Chen Y, et al
     The Association of Consumption Time for Food With Cardiovascular Disease and All-Cause Mortality Among Diabetic Patients.
     J Clin Endocrinol Metab. 2022 Mar 15. pii: 6546321. doi: 10.1210.
     PubMed     Abstract available
     
     
     
466. PERNG W, Friedman JE, Janssen RC, Glueck DH, et al
     Endotoxin biomarkers are associated with adiposity and cardiometabolic risk across 6 years of follow-up in youth.
     J Clin Endocrinol Metab. 2022 Mar 11. pii: 6547256. doi: 10.1210.
     PubMed     Abstract available
     
     
     
467. LI N, Li J, Wang H, Liu J, et al
     Branched-chain amino acids and their interactions with lipid metabolites for increased risk of gestational diabetes.
     J Clin Endocrinol Metab. 2022 Mar 10. pii: 6546670. doi: 10.1210.
     PubMed     Abstract available
     
     
     
468. GHOSH A, Dutta K, Bhatt SP, Gupta R, et al
     Dapagliflozin Improves Body Fat Patterning, and Hepatic and Pancreatic Fat in Patients with Type 2 Diabetes in North India.
     J Clin Endocrinol Metab. 2022 Mar 9. pii: 6545841. doi: 10.1210.
     PubMed     Abstract available
     
     
     
469. YU MG, King GL
     Inflammation and incident diabetes: the role of race and ethnicity.
     J Clin Endocrinol Metab. 2022 Mar 7. pii: 6543735. doi: 10.1210.
     PubMed    
     
     
     
470. LI Z, Veijola R, Koski E, Anand V, et al
     Childhood Height Growth Rate Association with the Risk of Islet Autoimmunity and Development of Type 1 Diabetes.
     J Clin Endocrinol Metab. 2022 Mar 4. pii: 6542469. doi: 10.1210.
     PubMed     Abstract available
     
     
     
471. SARATHI V
     Letter to the Editor from Sarathi: Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes.
     J Clin Endocrinol Metab. 2022 Mar 1. pii: 6540483. doi: 10.1210.
     PubMed    
     
     
     February 2022
472. WANG Y, Qin Y, Gu H, Zhang L, et al
     High Residual beta-cell Function in Chinese Patients with Autoimmune Type 1 Diabetes.
     J Clin Endocrinol Metab. 2022 Feb 26. pii: 6537636. doi: 10.1210.
     PubMed     Abstract available
     
     
     
473. STINSON SE, Jonsson AE, Fernandez de Retana Alzola I, Lund MAV, et al
     Hyperglucagonemia in pediatric adiposity associates with cardiometabolic risk factors but not hyperglycemia.
     J Clin Endocrinol Metab. 2022 Feb 25. pii: 6537120. doi: 10.1210.
     PubMed     Abstract available
     
     
     
474. EVERETT EM, Copeland TP, Moin T, Wisk LE, et al
     Insulin Pump Related Inpatient Admissions in a National Sample of Youth with Type 1 diabetes.
     J Clin Endocrinol Metab. 2022 Feb 23. pii: 6535117. doi: 10.1210.
     PubMed     Abstract available
     
     
     
475. LU J, Liu X, Jiang S, Kan S, et al
     Body Mass Index and Risk of Diabetic Nephropathy: A Mendelian Randomization Study.
     J Clin Endocrinol Metab. 2022 Feb 22. pii: 6529411. doi: 10.1210.
     PubMed     Abstract available
     
     
     
476. RUBIN MR, de Boer IH, Backlund JC, Arends V, et al
     Biochemical Markers of Bone Turnover in Older Adults with Type 1 Diabetes.
     J Clin Endocrinol Metab. 2022 Feb 21. pii: 6533648. doi: 10.1210.
     PubMed     Abstract available
     
     
     
477. GOU W, Yue L, Tang XY, Wu YY, et al
     Circulating proteome and progression of type 2 diabetes.
     J Clin Endocrinol Metab. 2022 Feb 20. pii: 6532660. doi: 10.1210.
     PubMed     Abstract available
     
     
     
478. 
     Corrigendum to: Duodenal Mucosal Expression of COVID-19-related Genes in Health, Diabetes Gastroenteropathy and Functional Dyspepsia.
     J Clin Endocrinol Metab. 2022 Feb 19. pii: 6532282. doi: 10.1210.
     PubMed    
     
     
     
479. FRITSCHE L, Heni M, Eckstein SS, Hummel J, et al
     Incretin hypersecretion in gestational diabetes mellitus.
     J Clin Endocrinol Metab. 2022 Feb 18. pii: 6532019. doi: 10.1210.
     PubMed     Abstract available
     
     
     
480. DE MELO EN, Clarke ABM, McDonald C, Saibil F, et al
     Gastrointestinal Symptoms in Type 1 Diabetes: Relationship with Autoimmune and Microvascular Complications.
     J Clin Endocrinol Metab. 2022 Feb 17. pii: 6530336. doi: 10.1210.
     PubMed     Abstract available
     
     
     
481. MESAS AE, Garrido-Miguel M, Fernandez-Rodriguez R, Fernandez Franco S, et al
     Egg Consumption and Blood Lipid Parameters According to the Presence of Chronic Metabolic Disorders: The EVIDENT II Study.
     J Clin Endocrinol Metab. 2022;107:e963-e972.
     PubMed     Abstract available
     
     
     
482. LEMOS JRN, Baidal DA, Poggioli R, Fuenmayor V, et al
     Prolonged Islet Allograft Function is Associated With Female Sex in Patients After Islet Transplantation.
     J Clin Endocrinol Metab. 2022;107:e973-e979.
     PubMed     Abstract available
     
     
     
483. OKAWA MC, Cochran E, Lightbourne M, Brown RJ, et al
     Long-Term Effects of Metreleptin in Rabson-Mendenhall Syndrome on Glycemia, Growth, and Kidney Function.
     J Clin Endocrinol Metab. 2022;107:e1032-e1046.
     PubMed     Abstract available
     
     
     
484. LEE SK, Park CY, Kim J, Kim D, et al
     TRIB3 Is Highly Expressed in the Adipose Tissue of Obese Patients and Is Associated With Insulin Resistance.
     J Clin Endocrinol Metab. 2022;107:e1057-e1073.
     PubMed     Abstract available
     
     
     
485. LIM IY, Lin X, Teh AL, Wu Y, et al
     Dichotomy in the Impact of Elevated Maternal Glucose Levels on Neonatal Epigenome.
     J Clin Endocrinol Metab. 2022;107:e1277-e1292.
     PubMed     Abstract available
     
     
     
486. HABIBY R, Bichet DG, Arthus MF, Connaughton D, et al
     A Novel form of Familial Vasopressin Deficient Diabetes Insipidus Transmitted in an X-linked Recessive manner.
     J Clin Endocrinol Metab. 2022 Feb 9. pii: 6524722. doi: 10.1210.
     PubMed     Abstract available
     
     
     
487. PEPER KM, Guo B, Long DL, Howard G, et al
     C-reactive protein and racial differences in type 2 diabetes incidence: The REGARDS study.
     J Clin Endocrinol Metab. 2022 Feb 8. pii: 6524616. doi: 10.1210.
     PubMed     Abstract available
     
     
     
488. ROA DUENAS OH, Van der Burgh AC, Ittermann T, Ligthart S, et al
     Thyroid Function and the Risk of Prediabetes and Type 2 Diabetes.
     J Clin Endocrinol Metab. 2022 Feb 5. pii: 6523041. doi: 10.1210.
     PubMed     Abstract available
     
     
     
489. VAN RUITEN CC, Veltman DJ, Schrantee A, van Bloemendaal L, et al
     Effects of dapagliflozin and combination therapy with exenatide on food-cue induced brain activation in patients with type 2 diabetes.
     J Clin Endocrinol Metab. 2022 Feb 3. pii: 6521281. doi: 10.1210.
     PubMed     Abstract available
     
     
     
490. MOHEET A, Moran A
     New concepts in the pathogenesis of cystic fibrosis-related diabetes.
     J Clin Endocrinol Metab. 2022 Feb 2. pii: 6519825. doi: 10.1210.
     PubMed     Abstract available
     
     
     
491. TANGPRICHA V
     Gender affirming hormone therapy and risk of diabetes in transgender persons.
     J Clin Endocrinol Metab. 2022 Feb 1. pii: 6519593. doi: 10.1210.
     PubMed    
     
     
     January 2022
492. YAPANIS M, James S, Craig ME, O'Neal D, et al
     Complications of diabetes and metrics of glycaemic management derived from continuous glucose monitoring.
     J Clin Endocrinol Metab. 2022 Jan 30. pii: 6517532. doi: 10.1210.
     PubMed     Abstract available
     
     
     
493. COLL JC, Garceau E, Leslie WD, Genest M, et al
     Prevalence of Vertebral Fractures in Adults with Type 1 Diabetes: DenSiFy Study (Diabetes Spine Fractures).
     J Clin Endocrinol Metab. 2022 Jan 28. pii: 6517001. doi: 10.1210.
     PubMed     Abstract available
     
     
     
494. DEB B, O'Brien DR, Bharucha AE
     Duodenal mucosal expression of COVID-19-related genes in health, diabetes gastroenteropathy and functional dyspepsia.
     J Clin Endocrinol Metab. 2022 Jan 28. pii: 6516815. doi: 10.1210.
     PubMed     Abstract available
     
     
     
495. AHMED F, Kamble PG, Hetty S, Fanni G, et al
     Role of estrogen and its receptors in adipose tissue glucose metabolism in pre- and postmenopausal women.
     J Clin Endocrinol Metab. 2022 Jan 27. pii: 6515919. doi: 10.1210.
     PubMed     Abstract available
     
     
     
496. WALLACE AS, Chang AR, Shin JI, Reider J, et al
     Obesity and Chronic Kidney Disease in US Adults With Type 1 and Type 2 Diabetes Mellitus.
     J Clin Endocrinol Metab. 2022 Jan 26. pii: 6511824. doi: 10.1210.
     PubMed     Abstract available
     
     
     
497. BEST CM, Zelnick LR, Thummel KE, Hsu S, et al
     Serum Vitamin D: Correlates of Baseline Concentration and Response to Supplementation in VITAL-DKD.
     J Clin Endocrinol Metab. 2022;107:525-537.
     PubMed     Abstract available
     
     
     
498. CHAN CL, Pyle L, Vigers T, Zeitler PS, et al
     The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic Fibrosis.
     J Clin Endocrinol Metab. 2022;107:e548-e560.
     PubMed     Abstract available
     
     
     
499. WANG X, Wu S, Yuan X, Chen S, et al
     Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
     J Clin Endocrinol Metab. 2022;107:e745-e755.
     PubMed     Abstract available
     
     
     
500. FATIMA F, Hjelmesaeth J, Birkeland KI, Gulseth HL, et al
     Gastrointestinal Hormones and beta-Cell Function After Gastric Bypass and Sleeve Gastrectomy: A Randomized Controlled Trial (Oseberg).
     J Clin Endocrinol Metab. 2022;107:e756-e766.
     PubMed     Abstract available
     
     
     
501. JONES B, Sands C, Alexiadou K, Minnion J, et al
     The Metabolomic Effects of Tripeptide Gut Hormone Infusion Compared to Roux-en-Y Gastric Bypass and Caloric Restriction.
     J Clin Endocrinol Metab. 2022;107:e767-e782.
     PubMed     Abstract available
     
     
     
502. PHAM DD, Song J, Jeon Y, Hajar I, et al
     Variability, mean, and baseline values of metabolic parameters in predicting the risk of type 2 diabetes.
     J Clin Endocrinol Metab. 2022 Jan 13. pii: 6506506. doi: 10.1210.
     PubMed     Abstract available
     
     
     
503. HATEM G, Hjort L, Asplund O, Minja DTR, et al
     Mapping the cord blood transcriptome of pregnancies affected by early maternal anemia to identify signatures of fetal programming.
     J Clin Endocrinol Metab. 2022 Jan 11. pii: 6503469. doi: 10.1210.
     PubMed     Abstract available
     
     
     
504. SINGHANIA P, Bhattacharjee R
     Letter to the Editor From Singhania et al: "Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger Adults".
     J Clin Endocrinol Metab. 2022 Jan 8. pii: 6501245. doi: 10.1210.
     PubMed    
     
     
     
505. CHAPLA A, Johnson J, Korula S, Mohan N, et al
     WFS1 gene associated diabetes phenotypes and identification of a founder mutation in Southern India.
     J Clin Endocrinol Metab. 2022 Jan 8. pii: 6501334. doi: 10.1210.
     PubMed     Abstract available
     
     
     
506. GUO J, Lin WW, Zucker JE, Nandakumar R, et al
     Inflammation and mortality in COVID-19 hospitalized patients with and without type 2 diabetes.
     J Clin Endocrinol Metab. 2022 Jan 6. pii: 6499340. doi: 10.1210.
     PubMed     Abstract available
     
     
     
507. PATTI G, Napoli F, Fava D, Casalini E, et al
     Approach To The Pediatric Patient: Central Diabetes Insipidus.
     J Clin Endocrinol Metab. 2022 Jan 5. pii: 6498061. doi: 10.1210.
     PubMed     Abstract available
     
     
     
508. RASOULI N, Brodsky IG, Chatterjee R, Kim SH, et al
     Effects of Vitamin D Supplementation on Insulin Sensitivity and Secretion in Prediabetes.
     J Clin Endocrinol Metab. 2022;107:230-240.
     PubMed     Abstract available
     
     
     
509. KIM SH, Park M, Kim GR, Joo HJ, et al
     Association of Mixed Use of Electronic and Conventional Cigarettes and Exposure to Secondhand Smoke With Prediabetes.
     J Clin Endocrinol Metab. 2022;107:e44-e56.
     PubMed     Abstract available
     
     
     
510. ABBARA A, Al-Memar M, Phylactou M, Daniels E, et al
     Changes in Circulating Kisspeptin Levels During Each Trimester in Women With Antenatal Complications.
     J Clin Endocrinol Metab. 2022;107:e71-e83.
     PubMed     Abstract available
     
     
     
511. KANEKO K, Ito Y, Ebara T, Kato S, et al
     Association of Maternal Total Cholesterol With SGA or LGA Birth at Term: the Japan Environment and Children's Study.
     J Clin Endocrinol Metab. 2022;107:e118-e129.
     PubMed     Abstract available
     
     
     
512. PATEL CHAVEZ C, Cusi K, Kadiyala S
     The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD.
     J Clin Endocrinol Metab. 2022;107:29-38.
     PubMed     Abstract available
     
     
     December 2021
513. VAN VELZEN D, Wiepjes C, Nota N, van Raalte D, et al
     Incident diabetes risk is not increased in transgender individuals using hormone therapy.
     J Clin Endocrinol Metab. 2021 Dec 31. pii: 6491237. doi: 10.1210.
     PubMed     Abstract available
     
     
     
514. DUGAN CW, Maloney SK, Abramoff KJ, Panag SS, et al
     Effects of simulated high altitude on blood glucose levels during exercise in individuals with Type 1 Diabetes.
     J Clin Endocrinol Metab. 2021 Dec 22. pii: 6464716. doi: 10.1210.
     PubMed     Abstract available
     
     
     
515. SATOMURA A, Oikawa Y, Haisa A, Suzuki S, et al
     Clinical significance of insulin peptide-specific interferon-gamma-related immune responses in ketosis-prone type 2 diabetes.
     J Clin Endocrinol Metab. 2021 Dec 18. pii: 6469690. doi: 10.1210.
     PubMed     Abstract available
     
     
     
516. TATSUKAWA Y, Cordova K, Yamada M, Ohishi W, et al
     Incidence of Diabetes in the Atomic Bomb Survivors: 1969-2015.
     J Clin Endocrinol Metab. 2021 Dec 16. pii: 6464273. doi: 10.1210.
     PubMed     Abstract available
     
     
     
517. WHERRY K, Zhu C, Vigersky RA
     Inequity in Adoption of Advanced Diabetes Technologies Among Medicare Fee-for-Service Beneficiaries.
     J Clin Endocrinol Metab. 2021 Dec 15. pii: 6458828. doi: 10.1210.
     PubMed     Abstract available
     
     
     
518. FENG L, Gao Q, Hu K, Wu M, et al
     Prevalence and risk factors of sarcopenia in patients with diabetes: A meta-analysis.
     J Clin Endocrinol Metab. 2021 Dec 14. pii: 6460766. doi: 10.1210.
     PubMed     Abstract available
     
     
     
519. WANG B, Wang Z, Poundarik AA, Zaki MJ, et al
     Unmasking Fracture Risk in Type 2 Diabetes: The Association of Longitudinal Glycemic Hemoglobin Level and Medications.
     J Clin Endocrinol Metab. 2021 Dec 9. pii: 6458464. doi: 10.1210.
     PubMed     Abstract available
     
     
     
520. DEMETERCO-BERGGREN C, Ebekozien O, Levy CJ, Maahs DM, et al
     Response to Letter to the Editor from Justin M. Gregory: Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study.
     J Clin Endocrinol Metab. 2021 Dec 6. pii: 6454277. doi: 10.1210.
     PubMed    
     
     
     
521. GREGORY JM, Moore DJ
     Letter to the Editor from Justin M. Gregory: Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study.
     J Clin Endocrinol Metab. 2021 Dec 6. pii: 6454284. doi: 10.1210.
     PubMed    
     
     
     
522. TIMOTHY GARVEY W
     New Horizons A New Paradigm for Treating to Target with Second-Generation Obesity Medications.
     J Clin Endocrinol Metab. 2021 Dec 5. pii: 6453059. doi: 10.1210.
     PubMed     Abstract available
     
     
     November 2021
523. ISLAM N, Nash R, Zhang Q, Panagiotakopoulos L, et al
     Is There a Link Between Hormone Use and Diabetes Incidence in Transgender People? Data from the STRONG Cohort.
     J Clin Endocrinol Metab. 2021 Nov 30. pii: 6429721. doi: 10.1210.
     PubMed     Abstract available
     
     
     
524. EL JELLAS K, Dusatkova P, Haldorsen IS, Molnes J, et al
     Two new mutations in the CEL gene causing diabetes and hereditary pancreatitis: How to correctly identify MODY8 cases.
     J Clin Endocrinol Metab. 2021 Nov 29. pii: 6446241. doi: 10.1210.
     PubMed     Abstract available
     
     
     
525. PRAHALAD P, Ding VY, Zaharieva DP, Addala A, et al
     Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Type 1 Diabetes: Pilot 4T Study.
     J Clin Endocrinol Metab. 2021 Nov 28. pii: 6445182. doi: 10.1210.
     PubMed     Abstract available
     
     
     
526. TRIOLO TM, Pyle L, Broncucia H, Armstrong T, et al
     Association of high-affinity autoantibodies with type 1 diabetes high-risk HLA haplotypes.
     J Clin Endocrinol Metab. 2021 Nov 27. pii: 6444375. doi: 10.1210.
     PubMed     Abstract available
     
     
     
527. YE Y, Xiong Y, Zhou Q, Xiao X, et al
     Early-pregnancy intermediate hyperglycaemia and adverse pregnancy outcomes among women without gestational diabetes.
     J Clin Endocrinol Metab. 2021 Nov 24. pii: 6437953. doi: 10.1210.
     PubMed     Abstract available
     
     
     
528. HERRERO-AGUAYO V, Saez-Martinez P, Lopez-Canovas JL, Prados-Carmona JJ, et al
     Dysregulation of Components of the Inflammasome Machinery After Bariatric Surgery: Novel Targets for a Chronic Disease.
     J Clin Endocrinol Metab. 2021;106:e4917-e4934.
     PubMed     Abstract available
     
     
     
529. VAN HEERWAARDE AA, Klomberg RCW, van Ravenswaaij-Arts CMA, Ploos van Amstel HK, et al
     Approach to Diagnosing a Pediatric Patient With Severe Insulin Resistance in Low- or Middle-income Countries.
     J Clin Endocrinol Metab. 2021;106:3621-3633.
     PubMed     Abstract available
     
     
     
530. KARCZEWSKA-KUPCZEWSKA M, Nikolajuk A, Stefanowicz M, Matulewicz N, et al
     Novel Laboratory Index, Based on Fasting Blood Parameters, Accurately Reflects Insulin Sensitivity.
     J Clin Endocrinol Metab. 2021;106:e5208-e5221.
     PubMed     Abstract available
     
     
     
531. ZHU J, Pujol-Gualdo N, Wittemans LBL, Lindgren CM, et al
     Evidence From Men for Ovary-independent Effects of Genetic Risk Factors for Polycystic Ovary Syndrome.
     J Clin Endocrinol Metab. 2021 Nov 19. pii: 6432124. doi: 10.1210.
     PubMed     Abstract available
     
     
     
532. SOVIO U, Goulding N, McBride N, Cook E, et al
     A Maternal Serum Metabolite Ratio Predicts Large for Gestational Age Infants at Term: A Prospective Cohort Study.
     J Clin Endocrinol Metab. 2021 Nov 19. pii: 6432237. doi: 10.1210.
     PubMed     Abstract available
     
     
     
533. XIE C, Huang W, Watson LE, Soenen S, et al
     Plasma GLP-1 response to oral and intraduodenal nutrients in health and type 2 diabetes - impact on gastric emptying.
     J Clin Endocrinol Metab. 2021 Nov 13. pii: 6427659. doi: 10.1210.
     PubMed     Abstract available
     
     
     
534. MORAN C, Than S, Callisaya M, Beare R, et al
     New Horizons - Cognitive dysfunction associated with type 2 diabetes.
     J Clin Endocrinol Metab. 2021 Nov 12. pii: 6426212. doi: 10.1210.
     PubMed     Abstract available
     
     
     
535. SAATMANN N, Zaharia OP, Strassburger K, Pesta DH, et al
     Physical fitness and cardiovascular risk factors in the novel diabetes subgroups.
     J Clin Endocrinol Metab. 2021 Nov 8. pii: 6423502. doi: 10.1210.
     PubMed     Abstract available
     
     
     
536. AU PCM, Tan KCB, Cheung BMY, Wong ICK, et al
     Association between SGLT2 Inhibitors vs DPP-4 Inhibitors and Risk of Pneumonia Among Patients with Type 2 Diabetes.
     J Clin Endocrinol Metab. 2021 Nov 8. pii: 6423245. doi: 10.1210.
     PubMed     Abstract available
     
     
     
537. ZHAO Y, Guo L, Jiang Y, Wu H, et al
     Assessment of Calf Skeletal Muscle in Male Type 2 Diabetes Mellitus Patients with Different Courses Using T1rho Mapping.
     J Clin Endocrinol Metab. 2021 Nov 8. pii: 6423242. doi: 10.1210.
     PubMed     Abstract available
     
     
     
538. POLLANEN PM, Harkonen T, Ilonen J, Toppari J, et al
     Autoantibodies to N-Terminally Truncated GAD65(96-585): HLA Associations and Predictive Value for Type 1 Diabetes.
     J Clin Endocrinol Metab. 2021 Nov 8. pii: 6423226. doi: 10.1210.
     PubMed     Abstract available
     
     
     
539. WANG DD, Qi Q, Wang Z, Usyk M, et al
     The Gut Microbiome Modifies the Association between a Mediterranean Diet and Diabetes in US Hispanic / Latino Population.
     J Clin Endocrinol Metab. 2021 Nov 8. pii: 6423197. doi: 10.1210.
     PubMed     Abstract available
     
     
     
540. ZUO Y, Han X, Tian X, Chen S, et al
     Association of Impaired Fasting Glucose with Cardiovascular Disease in the Absence of Risk Factor.
     J Clin Endocrinol Metab. 2021 Nov 8. pii: 6423498. doi: 10.1210.
     PubMed     Abstract available
     
     
     
541. HU J, Hu Y, Hertzmark E, Yuan C, et al
     Weight Change, Lifestyle and Mortality in Patients with Type 2 Diabetes.
     J Clin Endocrinol Metab. 2021 Nov 6. pii: 6422554. doi: 10.1210.
     PubMed     Abstract available
     
     
     
542. ECHOUFFO-TCHEUGUI JB, Kaze AD, Fonarow GC, Dagogo-Jack S, et al
     Severe Hypoglycemia and Incident Heart Failure among Adults With Type 2 Diabetes.
     J Clin Endocrinol Metab. 2021 Nov 6. pii: 6422471. doi: 10.1210.
     PubMed     Abstract available
     
     
     October 2021
543. QUANSAH DY, Gross J, Gilbert L, Pauchet A, et al
     Cardiometabolic and mental health in women with early gestational diabetes mellitus: A prospective cohort study.
     J Clin Endocrinol Metab. 2021 Oct 30. pii: 6414638. doi: 10.1210.
     PubMed     Abstract available
     
     
     
544. ROH E, Noh E, Hwang SY, Kim JA, et al
     Increased risk of type 2 diabetes in patients with thyroid cancer after thyroidectomy: A nationwide cohort study.
     J Clin Endocrinol Metab. 2021 Oct 28. pii: 6413717. doi: 10.1210.
     PubMed     Abstract available
     
     
     
545. GRIGGS S, Grey M, Strohl KP, Crawford SL, et al
     Variations in Sleep Characteristics and Glucose Regulation in Young Adults with Type 1 Diabetes.
     J Clin Endocrinol Metab. 2021 Oct 26. pii: 6410559. doi: 10.1210.
     PubMed     Abstract available
     
     
     
546. LEMAITRE M, Ternynck C, Bourry J, Baudoux F, et al
     Association between HbA1c levels on adverse pregnancy outcomes during pregnancy in type 1 diabetic patients.
     J Clin Endocrinol Metab. 2021 Oct 25. pii: 6409789. doi: 10.1210.
     PubMed     Abstract available
     
     
     
547. ANTONIO-VILLA NE, Fernandez-Chirino L, Vargas-Vazquez A, Fermin-Martinez CA, et al
     Prevalence trends of diabetes subgroups in the US: A data-driven analysis spanning three decades from NHANES (1988-2018).
     J Clin Endocrinol Metab. 2021 Oct 23. pii: 6409241. doi: 10.1210.
     PubMed     Abstract available
     
     
     
548. TUORILA K, Ollila MM, Jarvelin MR, Tapanainen JS, et al
     Hyperandrogenemia in Early Adulthood Is an Independent Risk Factor for Abnormal Glucose Metabolism in Middle Age.
     J Clin Endocrinol Metab. 2021;106:e4621-e4633.
     PubMed     Abstract available
     
     
     
549. CHAO CC, Tseng MT, Hsieh PC, Lin CJ, et al
     Brain mechanisms of pain and dysautonomia in diabetic neuropathy: connectivity changes in thalamus and hypothalamus.
     J Clin Endocrinol Metab. 2021 Oct 19. pii: 6403388. doi: 10.1210.
     PubMed     Abstract available
     
     
     
550. LEBLANC ES, Hillier TA
     The impact of gestational weight gain on glucose and insulin physiology in pregnancy-does timing matter?
     J Clin Endocrinol Metab. 2021 Oct 11. pii: 6388602. doi: 10.1210.
     PubMed    
     
     
     
551. PIRRO V, Roth KD, Lin Y, Willency JA, et al
     Effects of Tirzepatide, a Dual GIP and GLP-1 RA, on Lipid and Metabolite Profiles in Subjects with Type 2 Diabetes.
     J Clin Endocrinol Metab. 2021 Oct 5. pii: 6381509. doi: 10.1210.
     PubMed     Abstract available
     
     
     
552. HONG S, Park JH, Han K, Lee CB, et al
     Association between Obesity and Cardiovascular Disease in Elderly Patients with Diabetes: A Retrospective Cohort Study.
     J Clin Endocrinol Metab. 2021 Oct 1. pii: 6379050. doi: 10.1210.
     PubMed     Abstract available
     
     
     September 2021
553. DEMETERCO-BERGGREN C, Ebekozien O, Rompicherla S, Jacobsen L, et al
     Age and Hospitalization Risk in People with Type 1 Diabetes and COVID-19: Data from the T1D Exchange Surveillance Study.
     J Clin Endocrinol Metab. 2021 Sep 28. pii: 6374849. doi: 10.1210.
     PubMed     Abstract available
     
     
     
554. FAULDS ER, Boutsicaris A, Sumner L, Jones L, et al
     Use of Continuous Glucose Monitor in Critically Ill COVID-19 Patients Requiring Insulin Infusion: An Observational Study.
     J Clin Endocrinol Metab. 2021;106:e4007-e4016.
     PubMed     Abstract available
     
     
     
555. AGUILAR-RAMIREZ D, Alegre-Diaz J, Herrington WG, Staplin N, et al
     Association of Kidney Function With NMR-Quantified Lipids, Lipoproteins, and Metabolic Measures in Mexican Adults.
     J Clin Endocrinol Metab. 2021;106:2828-2839.
     PubMed     Abstract available
     
     
     
556. CINTRA RM, Nogueira AC, Bonilha I, Luchiari BM, et al
     Glucose-lowering Drugs and Hospitalization for Heart Failure: A Systematic Review and Additive-effects Network Meta-analysis With More Than 500 000 Patient-years.
     J Clin Endocrinol Metab. 2021;106:3060-3067.
     PubMed     Abstract available
     
     
     
557. LANDSTRA CP, Andres A, Chetboun M, Conte C, et al
     Examination of the Igls Criteria for Defining Functional Outcomes of beta-cell Replacement Therapy: IPITA Symposium Report.
     J Clin Endocrinol Metab. 2021;106:3049-3059.
     PubMed     Abstract available
     
     
     
558. KAYGUSUZ SB, Arslan Ates E, Vignola ML, Volkan B, et al
     Dysgenesis and Dysfunction of the Pancreas and Pituitary Due to FOXA2 Gene Defects.
     J Clin Endocrinol Metab. 2021;106:e4142-e4154.
     PubMed     Abstract available
     
     
     
559. POTTER KJ, Reynaud Q, Boudreau V, Racine F, et al
     Combined Indeterminate and Impaired Glucose Tolerance Is a Novel Group at High Risk of Cystic Fibrosis-Related Diabetes.
     J Clin Endocrinol Metab. 2021;106:e3901-e3910.
     PubMed     Abstract available
     
     
     
560. WANG Y
     Definition, Prevalence, and Risk Factors of Low Sex Hormone-Binding Globulin in US Adults.
     J Clin Endocrinol Metab. 2021;106:e3946-e3956.
     PubMed     Abstract available
     
     
     
561. LU Q, Wan Z, Guo J, Liu L, et al
     Association Between Serum 25-hydroxyvitamin D Concentrations and Mortality Among Adults With Prediabetes.
     J Clin Endocrinol Metab. 2021;106:e4039-e4048.
     PubMed     Abstract available
     
     
     
562. ALMBY KE, Katsogiannos P, Pereira MJ, Karlsson FA, et al
     Time Course of Metabolic, Neuroendocrine, and Adipose Effects During 2 Years of Follow-up After Gastric Bypass in Patients With Type 2 Diabetes.
     J Clin Endocrinol Metab. 2021;106:e4049-e4061.
     PubMed     Abstract available
     
     
     
563. AYE ILMH, Rosario FJ, Kramer A, Kristiansen O, et al
     Insulin increases adipose adiponectin in pregnancy by inhibiting ubiquitination and degradation: Impact of obesity.
     J Clin Endocrinol Metab. 2021 Sep 14. pii: 6370132. doi: 10.1210.
     PubMed     Abstract available
     
     
     
564. HUANG R, Dong Y, Levy E, Julien P, et al
     Large-for-gestational-age, leptin and adiponectin in infancy.
     J Clin Endocrinol Metab. 2021 Sep 3. pii: 6363651. doi: 10.1210.
     PubMed     Abstract available
     
     
     
565. LINDSAY KL, Gyllenhammer LE, Entringer S, Wadhwa PD, et al
     Rate of gestational weight gain and glucose-insulin metabolism among Hispanic pregnant women with overweight and obesity.
     J Clin Endocrinol Metab. 2021 Sep 1. pii: 6360972. doi: 10.1210.
     PubMed     Abstract available
     
     
     August 2021
566. WANG J, Wang Z, Guo F, Zhang Y, et al
     Individual and combined cardiometabolic morbidities and the subsequent risk of cardiovascular events in Chinese adults.
     J Clin Endocrinol Metab. 2021 Aug 24. pii: 6357056. doi: 10.1210.
     PubMed     Abstract available
     
     
     
567. KEATING B, Smart CEM, Harray AJ, Paramalingam N, et al
     Additional Insulin Is Required in Both the Early and Late Postprandial Periods for Meals High in Protein and Fat: A Randomized Trial.
     J Clin Endocrinol Metab. 2021;106:e3611-e3618.
     PubMed     Abstract available
     
     
     
568. KWAK SH, Powe CE, Jang SS, Callahan MJ, et al
     Sequencing Cell-free Fetal DNA in Pregnant Women With GCK-MODY.
     J Clin Endocrinol Metab. 2021;106:2678-2689.
     PubMed     Abstract available
     
     
     
569. CHATTERJEE R, Fuss P, Vickery EM, LeBlanc ES, et al
     Vitamin D Supplementation for Prevention of Cancer: The D2d Cancer Outcomes (D2dCA) Ancillary Study.
     J Clin Endocrinol Metab. 2021;106:2767-2778.
     PubMed     Abstract available
     
     
     July 2021
570. LEBLANC ES, Smith NX, Vesco KK, Hillier TA, et al
     Weight Loss Prior to Pregnancy and Early Gestational Glycemia: Prepare, a Randomized Clinical Trial.
     J Clin Endocrinol Metab. 2021 Jul 27. pii: 6329123. doi: 10.1210.
     PubMed     Abstract available
     
     
     
571. FARHY LS
     Developmental Patterns of Glycemic Control in T1D and Their Association With Demographic and Clinical Variables.
     J Clin Endocrinol Metab. 2021;106:e3261-e3263.
     PubMed    
     
     
     
572. LI L, Sun J, Ruan L, Song Q, et al
     Time-Series Analysis of Continuous Glucose Monitoring Data to Predict Treatment Efficacy in Patients with T2DM.
     J Clin Endocrinol Metab. 2021;106:2187-2197.
     PubMed     Abstract available
     
     
     
573. JIMENEZ-VACAS JM, Montero-Hidalgo AJ, Gomez-Gomez E, Fuentes-Fayos AC, et al
     In1-ghrelin splicing variant as a key element in the pathophysiological association between obesity and prostate cancer.
     J Clin Endocrinol Metab. 2021 Jul 13. pii: 6320612. doi: 10.1210.
     PubMed     Abstract available
     
     
     June 2021
574. WOLFGRAM PM, Cabrera SM
     Youth Along the T2D Risk Continuum Remain Concerningly Refractory to Therapeutic Interventions.
     J Clin Endocrinol Metab. 2021;106:e2803-e2805.
     PubMed    
     
     
     
575. LIN DS, Lee JK, Chen WJ
     Clinical Adverse Events Associated with Sodium-Glucose Cotransporter 2 Inhibitors: A Meta-Analysis Involving 10 Randomized Clinical Trials and 71 553 Individuals.
     J Clin Endocrinol Metab. 2021;106:2133-2145.
     PubMed     Abstract available
     
     
     
576. CORDINER RLM, Mari A, Tura A, Pearson ER, et al
     The Impact of Low-dose Gliclazide on the Incretin Effect and Indices of Beta-cell Function.
     J Clin Endocrinol Metab. 2021;106:2036-2046.
     PubMed     Abstract available
     
     
     May 2021
577. KIM JA, Lee JS, Song E, Roh E, et al
     Association between Visit-to-Visit Fasting Plasma Glucose Variability and Osteoporotic Fractures in nondiabetic subjects.
     J Clin Endocrinol Metab. 2021 May 26. pii: 6284334. doi: 10.1210.
     PubMed     Abstract available
     
     
     
578. WANG P, Xie J, Jiao XC, Ma SS, et al
     Maternal Glycemia during pregnancy and Early Offspring Development: A Prospective Birth Cohort Study.
     J Clin Endocrinol Metab. 2021 May 13. pii: 6274865. doi: 10.1210.
     PubMed     Abstract available
     
     
     
579. DANNECKER C, Wagner R, Peter A, Hummel J, et al
     Low-Density Lipoprotein Cholesterol Is Associated With Insulin Secretion.
     J Clin Endocrinol Metab. 2021;106:1576-1584.
     PubMed     Abstract available
     
     
     
580. KUBOTA S, Yabe D
     Elevation of fasting GLP-1 levels in child and adolescent obesity: Friend or foe?
     J Clin Endocrinol Metab. 2021 May 5. pii: 6266257. doi: 10.1210.
     PubMed     Abstract available
     
     
     April 2021
581. TOSCHI E, Bailey RJ, Miller KM, Calhoun PM, et al
     Improvement in A1c Levels in Early Adulthood in the T1D Exchange: Impact of Racial, Socioeconomic, and Clinical Factors.
     J Clin Endocrinol Metab. 2021;106:1294-1302.
     PubMed     Abstract available
     
     
     
582. FUKUDA S, Kita S, Miyashita K, Iioka M, et al
     Identification and Clinical Associations of 3 Forms of Circulating T-cadherin in Human Serum.
     J Clin Endocrinol Metab. 2021;106:1333-1344.
     PubMed     Abstract available
     
     
     
583. RIDDLE MC, Gerstein HC, Xavier D, Cushman WC, et al
     Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial.
     J Clin Endocrinol Metab. 2021;106:1345-1351.
     PubMed     Abstract available
     
     
     
584. CHEN X, Maldonado E, DeFronzo RA, Tripathy D, et al
     Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function.
     J Clin Endocrinol Metab. 2021;106:1398-1409.
     PubMed     Abstract available
     
     
     
585. WU F, Pahkala K, Juonala M, Rovio SP, et al
     Dietary Pattern Trajectories from Youth to Adulthood and Adult Risk of Impaired Fasting Glucose: A 31-year Cohort Study.
     J Clin Endocrinol Metab. 2021;106:e2078-e2086.
     PubMed     Abstract available
     
     
     
586. PELLEGRINI S, Pipitone GB, Cospito A, Manenti F, et al
     Generation of beta Cells from iPSC of a MODY8 Patient with a Novel Mutation in the Carboxyl Ester Lipase (CEL) Gene.
     J Clin Endocrinol Metab. 2021;106:e2322-e2333.
     PubMed     Abstract available
     
     
     March 2021
587. 
     Addressing Insulin Access and Affordability: An Endocrine Society Position Statement.
     J Clin Endocrinol Metab. 2021;106:935-941.
     PubMed     Abstract available
     
     
     
588. NOBREGA S, Monteiro MP, Pereira-da-Silva L, Pereira SS, et al
     Congenital Glucagon-like Peptide-1 Deficiency in the Pathogenesis of Protracted Diarrhea in Mitchell-Riley Syndrome.
     J Clin Endocrinol Metab. 2021;106:1084-1090.
     PubMed     Abstract available
     
     
     
589. ZHOU JJ, Koska J, Bahn G, Reaven P, et al
     Fasting Glucose Variation Predicts Microvascular Risk in ACCORD and VADT.
     J Clin Endocrinol Metab. 2021;106:1150-1162.
     PubMed     Abstract available
     
     
     
590. CHA AS, Chen Y, Fazioli K, Rivara MB, et al
     Microvascular Benefits of New Antidiabetic Agents: A Systematic Review and Network Meta-Analysis of Kidney Outcomes.
     J Clin Endocrinol Metab. 2021;106:1225-1234.
     PubMed     Abstract available
     
     
     
591. KELSEY MM, Hilkin A, Laura P, Cameron S, et al
     Two-year treatment with metformin during puberty does not preserve beta-cell function in youth with obesity.
     J Clin Endocrinol Metab. 2021 Mar 17. pii: 6174419. doi: 10.1210.
     PubMed     Abstract available
     
     
     
592. LIU Y, Guo F, Zhou Y, Yang X, et al
     The interactive effect of pre-pregnancy overweight/obesity and isolated maternal hypothyroxinemia on macrosomia.
     J Clin Endocrinol Metab. 2021 Mar 15. pii: 6171086. doi: 10.1210.
     PubMed     Abstract available
     
     
     
593. PICCOLI GF, Mesquita LA, Stein C, Aziz M, et al
     Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer? A Systematic Review and Meta-analysis.
     J Clin Endocrinol Metab. 2021;106:912-921.
     PubMed     Abstract available
     
     
     
594. TAO T, Zhang Y, Zhu YC, Fu JR, et al
     Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study.
     J Clin Endocrinol Metab. 2021;106:e1420-e1432.
     PubMed     Abstract available
     
     
     
595. JOHAM AE, Kakoly NS, Teede HJ, Earnest A, et al
     Incidence and Predictors of Hypertension in a Cohort of Australian Women with and without Polycystic Ovary Syndrome.
     J Clin Endocrinol Metab. 2021 Mar 8. pii: 6161509. doi: 10.1210.
     PubMed     Abstract available
     
     
     
596. CASTELLANA M, Procino F, Biacchi E, Zupo R, et al
     Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy for Remission of Type 2 Diabetes.
     J Clin Endocrinol Metab. 2021;106:922-933.
     PubMed     Abstract available
     
     
     February 2021
597. PETRY CJ, Burling KA, Barker P, Hughes IA, et al
     Pregnancy Serum DLK1 Concentrations are associated with Indices of Insulin Resistance and Secretion.
     J Clin Endocrinol Metab. 2021 Feb 26. pii: 6153468. doi: 10.1210.
     PubMed     Abstract available
     
     
     
598. VIGEVANO F, Gregori G, Colleluori G, Chen R, et al
     In Men With Obesity, T2DM Is Associated With Poor Trabecular Microarchitecture and Bone Strength, and Low Bone Turnover.
     J Clin Endocrinol Metab. 2021 Feb 4. pii: 6127536. doi: 10.1210.
     PubMed     Abstract available
     
     
     January 2021
599. GUBBI S, Muniyappa R, Sharma ST, Grewal S, et al
     Mifepristone improves adipose tissue insulin sensitivity in insulin resistant individuals.
     J Clin Endocrinol Metab. 2021 Jan 28. pii: 6122543. doi: 10.1210.
     PubMed     Abstract available
     
     
     December 2020
600. LIU H, Liang SY, Li Y, Fu JL, et al
     A novel type of extreme insulin resistance: nonhypoglycaemic insulin autoimmune syndrome.
     J Clin Endocrinol Metab. 2020 Dec 31. pii: 6056476. doi: 10.1210.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.